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ABSTRACT 
The PI3K/ Akt/mTOR pathway regulates several cellular functions, including 
cellular proliferation, growth, and survival. The PI3K/ Akt/mTOR pathway 
converges on the eukaryotic translation initiation factor 4F (eiF4F), making it an 
attractive molecular target for anti-cancer therapies. As a subunit of eiF4F, eiF4A is 
known to facilitate binding and scanning of the ribosome by unwinding secondary 
structures in the 5' untranslated region (UTR) of mRNAs. However, the molecular 
mechanisms of eiF4A activity have remained elusive. 
Single-molecule Fluorescence Resonance Energy Transfer (sm-FRET) can 
probe structural changes and interactions of biological systems in real time, which 
cannot be observed using bulk techniques. First we directly observe and quantify 
the helicase activity of eiF4A in the presence of the ancillary RNA-binding factor 
eiF4H using sm-FRET. We show that eiF4H can significantly enhance the helicase 
activity of eiF4A by strongly binding both to loop structures within the RNA 
vii 
substrate as well as to eiF4A. Electrophoretic mobility shift assay (EMSA) shows 
that eiF4H binds to the amino-terminal domain (NTD) but not to the carboxy-
terminal domain (CTD) of eiF4A. In the presence of ATP, the eiF4AjeiF4H complex 
exhibits rapid and repetitive cycles of unwinding and re-annealing. ATP titration 
assays suggest that this process consumes a single ATP molecule per cycle. Second, 
we directly probe the conformational dynamics of eiF4A, in real time, using sm-
FRET. We demonstrate that the eiF4A in the presence of eiF4H can repetitively 
unwind the RNA hairpin substrate by transitioning between an "open" and a 
"closed" conformation using the energy from ATP hydrolysis. Upon binding of an 
RNA hairpin and ATP, which is mediated by eiF4H, eiF4A adopts a closed 
conformation; after ATP hydrolysis, eiF4A returns to the open conformation and the 
RNA duplex is completely unwound. Then the eiF4A releases the RNA and the 
hairpin is quickly reformed. Third, we find that RNA aptamer and the small molecule 
hippuristanol can inhibit the binding to the RNA substrate or the helicase activity of 
the eiF4AjeiF4H complex respectively. The RNA aptamer can directly compete with 
an RNA hairpin for binding to both eiF4A and eiF4H. Hippuristanol inhibits helicase 
activity by blocking the conformational change of eiF4A. 
viii 
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Chapter 1: Introduction 
1.1 PI3K/ AKT /mTOR signaling pathway and cancer 
Cell stress activates signaling pathways, allowing cells to choose between 
survival and apoptosis. The phosphatidylinositol-3-kinase (PI3K)/ Aktfmammalian 
target ofrapamycin (mTOR) signaling pathway plays a critical role in the regulation 
of cellular growth, survival, and proliferation (1). Furthermore, the 
PI3K/ AKT fmTOR signaling pathway is a key pathway frequently upregulated in a 
variety of human cancer cells (2-4) and it has emerged as a key target for the 
treatment of cancer, particularly in the treatment of tumors that exhibit increased 
mTOR signaling as a result of genetic lesions (5, 6). 
Most of the pathways that are crucial for cancer development and 
progression affect translation control. These include the selective translation of 
mRNAs encoding proteins that are engaged in tumor cell proliferation, growth, 
angiogenesis, and tumor stress responses (7). Alterations in the expression and 
activity of specific translation factors, and the uncoupling of translational regulation 
from inhibition by tumor cell stresses, such as hypoxia and nutrient deprivation, are 
a common feature of human cancers (3, 4, 8). These alterations are associated with 
specific types of human cancers and different stages of disease and cellular 
transformation. Targeting specific translation factors that are altered in expression 
or activity in human cancers, and the specialized mRNA translation elements used 
preferentially in tumors, offers great promise for the development of a new 
1 
generation of cancer therapeutics (9-15). By focusing on molecular and cellular 
changes that are specific to cancer and using drugs to block the growth and spread 
of cancer by interfering with specific molecules, targeted cancer therapies may be 
more effective than other types of treatment, including chemotherapy 
and radiotherapy, and less harmful to normal cells. 
Cap-dependent ..,._ __ 
translation 
Figure 1-The PI3K/ AKT jmTOR signaling pathway is central to translational 
regulation and is an important target in cancer therapeutics. The RasjErk/MAPK 
pathway, like the PI3K/ Akt pathway, is also often upregulated in human cancers, and 
similarly affects several downstream effector pathways, including mTOR. Figure adapted 
from 1 . 
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1.2 Translation regulation as a therapeutic target in cancer 
Aberrant function of components of the translation machinery underlies a 
variety of human diseases including certain cancers and metabolic disorders. Cancer 
is associated with aberrant changes in the amounts and activities of translation 
initiation factors and regulatory factors. A strong causal relationship between levels 
of expression and cancer was established for eiF4E, and the overexpression of eiF4E 
causes malignanttransformation of human and mouse cells (8, 16, 17). 
Activation of the mTOR pathway by PI3K/ Akt signaling that in turn activates 
cap-dependent mRNA translation is frequently observed in human cancers (1, 13). 
Mounting evidence links deregulated protein synthesis to tumorigenesis via the 
translation initiation factor complex eiF4F (Figure 1). Components of this complex 
are often overexpressed in a large number of cancers. 
Deregulated translation initiation is implicated extensively in cancer 
initiation and progression. Several translation initiation factors cooperate with 
known oncogenes, are elevated in human tumors and have been implicated in drug 
resistance. Consequently, there is a great deal of interest in targeting this process to 
develop new chemotherapeutics (18, 19), especially since clinical trial results have 
been mixed when targeting upstream pathways, such as the mammalian target of 
rapamycin (mTOR). Several inhibitors have been characterized that target the 
ribosome recruitment phase eukaryotic initiation factor eiF4E (4EGI-1) (20) or 
eiF4A (pateamine A, hippuristanol and silvestrol) (21-24), some of which 
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demonstrate activity in preclinical cancer models. The promise of these inhibitors as 
chemotherapeutics highlights the importance of targeting this pathway and 
supports efforts aimed at identifying the most susceptible targets. In addition, the 
framework in which translation inhibitors would be best employed in the clinic 
remains to be explored systematically. Small-molecule inhibitors of translation 
initiation are validating the idea that protein synthesis is a legitimate target for 
curtailing tumor growth (25, 26). 
eiF4A has three isoforms: eiF4AI, eiF4AII and eiF4AIII. eiF4AI and eiF4AII 
are two highly related eiF4A gene products (90-95% identical at the amino acid 
level), both implicated in translation and functionally interchangeable in vitro (27, 
28). eiF4AIII is 65% similar to the other isoforms and is implicated in nonsense-
mediated decay (29, 30). Here we focus on eiF4AI and refer to it as eiF4A 
throughout this thesis. 
It was observed that eiF4A mRNA is overexpressed approximately five fold 
in melanoma cells in tissue culture compared to normal melanocytes (31). In human 
tissue, eiF4A mRNA was found to be upregulated in hepatocellular carcinomas (32). 
It has been reported that eiF4A is overexpressed in some primary hepatocellular 
carcinomas, in human melanoma cell lines and in some primary melanomas (26) . 
Therefore, eiF4A is a potential anti proliferative target. For instance, the tumor 
suppressor programmed cell death protein 4 (Pdcd4) is known to bind to eiF4A and 
thereby inhibit cap-dependent translation (33, 34). Some natural compounds, 
4 
pateamine (24, 35) and silvestrol (23), have been identified that inhibit initiation of 
translation by interacting with eiF4A. It is shown that silvestrol has potent 
anticancer activity in breast and prostate tumor xenograft models (23) . 
1.3 Eukaryotic translation initialization 
1.3.1 Eukaryotic translation initialization factors 
Eukaryotic translation is the process by which messenger 
RNA is translated into proteins. It consists of 3 steps: initiation, elongation and 
termination. Protein synthesis is mainly regulated at the initiation step, allowing the 
fast, reversible and spatial control of gene expression (36) . 
The initiation of protein synthesis in eukaryotes is a highly regulated process 
involving at least 12 protein factors as shown in Table 1.1(37). eiF4F is composed of 
three initiation factors: eiF4E, a cap binding protein; eiF4A, an ATP-dependent RNA 
helicase; and eiF4G, a scaffolding protein which binds eiF4E and eiF4A(Figure 2), as 
well as the multi-subunit eiF3 complex and the poly-A binding protein (PABP). 
5 
ATP ~~ 
ADP+ Pi <;J 
-----
mRNA 
Unwinding secondary 
structure of 5' UTR 
Ribosome scanning and release of n Initiation fa<"" 
Figure 2 -Eukaryotic translation initiation. The cap-binding complex, which 
consists ofeiF4E (4E), eiF4G (4G) and eiF4A (4A), binds to the 7-methyl-GTP (m7GTP) cap 
structure at the 5' end of a messenger RNA (mRNA). eiF4G also binds to the poly(A)-binding 
protein (PABP), thereby bridging the 5' and 3' ends of the mRNA. This mRNA circularization 
and the ATP-dependent helicase activity of eiF4A are thought to promote the binding of the 
43S pre-initiation complex to the mRNA, which produces a 48S pre-initiation complex. 
Following scanning of the ribosome to the AUG start codon, GTP is hydrolyzed by eiF2, 
which triggers the dissociation of factors from the 48S complex and allows the eiF5B- and 
GTP-dependent binding of the large, 60S ribosomal subunit. 
eiF4B and eiF4H are RNA chaperones implicated in the ribosome 
recruitment phase via their enhancement of eiF4A helicase activity (Figure 2). eiF4B 
is a dimeric protein (70 kDa subunit) that has no independent catalytic activity and 
functions to stimulate the RNA binding, ATPase, and helicase activities of eiF4A 
6 
(38) .eiF4B is a known phosphorylation target of the mTOR/PI3K and MAPK signal 
transduction pathways (39) as shown in Figure 1. In response to hormones and 
nutrient sufficiency, increased eiF4B phosphorylation promotes its association with 
the translation initiation complex, where it is thought to enhance translation 
initiation by stimulating the activity of eiF4A. 
The eiF4H gene is known to produce two splice variants, isoform 1 (eiF4HL) 
and 2 (eiF4Hs) (exon 5 is alternatively spliced), which generate two protein 
products, 27 kDa and 25 kDa (25, 40). It is suggested that eiF4H functions in 
translation initiation through protein-protein interactions that possibly stabilize 
conformational changes of eiF4A during RNA binding and RNA duplex 
unwinding(41). Although both 4B and 4H contain a well-defined RNA recognition 
motif (RRM) ( 42, 43), 4B and 4H bear very little sequence similarity to one another. 
eiF4H, like eiF4B, enhances the helicase activity of eiF4A and contains an RRM that 
shows sequence homology to eiF4B in this region-however, the two proteins are 
dissimilar in their mechanism of action and their influence on eiF4A RNA binding 
and ATPase activity (38). Even though both 4B and 4H can share a common binding 
site on 4A, it was shown that there was a difference between the expression of 
eiF4B and eiF4H mRNA in several tissues, and may suggest tissue-specific functions 
of the factors with varying mRNAs. However, how the helicase activity of eiF4A is 
modulated by eiF4B and eiF4H still remains elusive. 
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Number of 
Name subunits and Function their molecular 
mass (kDa) 
Core initiation {actors 
Forms an eiF2-GTP-Met-tRNAi ternary complex that 
3 (36.1, 38.4 and binds to the 40S subunit, thus mediating ribosomal 
eiF2 51.1) recruitment of Met-tRNAi 
Binds 40S subunits, eiF1, eiF4G and eiF5; stimulates 
binding of eiF2-GTP-Met-tRNAi to 40S subunits; 
promotes attachment of 43S complexes to mRNA and 
subsequent scanning; and possesses ribosome 
dissociation and anti-association activities, preventing 
eiF3 13 (800 total) I joining of 40S and 60S subunits 
Ensures the fidelity of initiation codon selection; 
promotes ribosomal scanning; stimulates binding of 
eiF2-GTP-Met-tRNAi to 40S subunits; and prevents 
premature eiF5-induced hydrolysis of eiF2-bound GTP 
eiF1 1 (12.7) and Pi release 
Stimulates binding of eiF2-GTP-Met-tRNAi to 40S 
subunits and cooperates with eiF1 in promoting 
eiF1A 1 (16.5) ribosomal scanning and initiation codon selection 
Binds to the m7GpppG 5' terminal'cap' structure of 
eiF4E 1 (24.5) mRNA 
eiF4A* 1 (46.1) DEAD-box ATPase and ATP-dependent RNA helicase 
Binds eiF4E, eiF4A, eiF3, PABP, SLIP1 and mRNA and 
eiF4G* 1 (175.5) enhances the helicase activ!!Y of elF4A 
A cap-binding complex, comprising eiF4E, eiF4A and 
eiF4G; unwinds the 5' proximal region of mRNA and 
mediates the attachment of 43S complexes to it; and 
eiF4F 3 (246.1 total) assists ribosomal complexes during scanning 
An RNA-binding protein that enhances the helicase 
eiF4B 1 (69.3) activity of eiF4A 
An RNA-binding protein that enhances the helicase 
activity of eiF4A and is homologous to a fragment of 
eiF4H 1 (27.4) eiF4B 
A GTPase-activating protein, specific for GTP-bound 
eiF2, that induces hydrolysis of eiF2-bound GTP on 
eiF5 1 (49.2) recognition of the initiation codon 
A ribosome-dependent GTPase that mediates ribosomal 
eiF5B 1 (138.9) subunit joining 
5 (33. 7, 39.0, 50.2, A guanosine nucleotide exchange factor that promotes 
eiF2B 59.7 and 80.3) GDP-GTP exchange on eiF2 
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Auxiliary factors 
A DExH box-containing protein that binds 40S subunit 
and promotes ribosomal scanning on mRNAs with long, 
DHX29 1 (155.3) highly structured 5' UTRs 
A DEAD box-containing NTPase and RNA helicase that 
potentially promotes scanning in Saccharomyce 
Ded1 1 (65.6) scerevisiae 
An anti-association factor that binds 60S subunits and 
eiF6 1 (26.6) I prevents them from joining to 40S subunits 
Closely related to the carboxy-terminal two-thirds of 
eiF4G; binds eiF4A and eiF3; and promotes initiation in a 
lp97 1 (102.4) I potentially mRNA-specific manner 
Binds to the 3' poly(A) tail ofmRNA, eiF4G and eRF3; 
enhances binding of eiF4F to the cap; and might facilitate 
recruitment of recycled post-termination 40S subunits 
PABP 1 (70.7) back to the 5' end of mRNA 
Ded1, DEAD box helicase 1; DHX29, DExH box protein 29; elF, eukaryotic initiation 
factor; PABP, poly(A)-binding protein. 
*Two paralogues ( eiF4A and eiF4AI), encoded by different genes, are functionally 
indistinguishable, but eiF4AIII has no activity as an elF. 
*Two paralogues ( eiF4GI and eiF4GII), encoded by different genes, are functionally 
similar but show some selectivity towards different mRNAs. eiF4GI is generally the 
more abundant. 
Table 1.1-Eukaryotic initiation factors (37) 
1.3.2 5'- untranslated regions and the role of eiF4A 
The 5' untranslated regions (UTR) of eukaryotic mRNAs play crucial roles in 
the posttranscriptional regulation of gene expression. It has been hypothesized that 
translational efficiency is determined by the amount of secondary structure in the 
5'-UTR of mRNA (44). The requirement for elF4A in translation is in direct 
proportion to the degree of mRNA 5' secondary structure (45). The average length 
of the 5'-UTR of mRNAs in humans is 210 nt and the minimum length has been 
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shown to be 18 nt. The 5' -UTR of the Tre oncogene mRNA (2858 nt) is the longest 
known 5'-UTR in humans (46). The length of the 5'-UTR influences the translation 
efficiency by determining the energy a navigating ribosome needs to reach the AUG 
through a highly structured 5' -UTR. 
1.3. 3 Cap-dependent translation Initiation 
Cap dependent translation initiation is instigated by the binding of the eiF4F 
complex to the 5' cap-structure of the mRNA, which serves to recruit the 43S pre-
initiation complex at the 5' end of the mRNA (Figure 2). The bridge between eiF4G 
and eiF3 is critical as it facilitates recruitment of the 43S complex to the mRNA ( 4 7). 
The 43S complex is then thought to scan along the mRNA until the 
appropriate start codon is recognized. Once the correct position is found, the 60S 
ribosomal subunit joins and factors dissociate allowing the elongation phase to 
begin. The rate-limiting step of this process is thought to be the recruitment of the 
43S preinitiation complex to the mRNA, with eiF4F being the major driver of this 
biochemical reaction. 
1.3.4 IRES-dependent translation Initiation 
Internal ribosome entry sites (IRES) elements are highly structured RNA 
sequences that function to recruit ribosomes for the initiation of translation. 
IRES elements, first discovered in viral RNA genomes ( 48, 49), were subsequently 
found in a subset of cellular RNAs as well (50). These cellular IRES-
containing mRNAs appear to play important roles during conditions 
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of cellular stress, development, and disease (51). Initiation factors and/or the 
ribosome can bind directly to the IRES, thereby initiating translation in a cap-
independent manner (Figure 3) (52). 
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Figure 3 -Hepatitis C virus ribosome recruitment strategy and IRES secondary 
structure. (A)Comparison of canonical eukaryotic cap-dependent translation initiation 
and the internal initiation mechanism used by hepatitis C virus (bottom). Cap-dependent 
translation requires recognition of a modified nucleotide at the 5' terminus of the mRNA 
by the eiF4F complex, which includes eiF-4G, eiF-4E, eiF-4B, and eiF-4A. The 43S particle 
(40SsubunitfeiF3/Met-tRNA/eiF2/GTP) binds to the mRNA/eiF4F complex primarily 
through interactions between eiF3 and eiF4G. In contrast, HCV IRES-driven translation 
initiation occurs through direct, specific recognition of the 40S subunit and eiF3 by the 
IRES RNA tertiary structure, eliminating the need for the cap-structure and cap-binding 
factors. (B) Schematic secondary structures of the HCV IRES RNA constructs used in this 
study. The full-length construct (left) consists of nucleotides 40 to 372 of HCV IRES 
genotype lb, and is fully active in initiation translation. (C) Locations within the 
secondary structure and sizes of RNA helices that were fit into the HCV IRES density. 
Figure adapted from (53). 
The presence of Upstream Open Reading Frames (uORFs) on transcripts 
containing IRESes may reduce the number of scanning ribosomes (54). This reduces 
the frequency of ribosomes which could potentially translate through the IRES and 
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disrupt its secondary structure. It has also been reported that scanning ribsomes 
can regulate RNA/RNA interactions in the IRES, thereby activating IRES-mediated 
translation (55) . These examples suggest that interplay between cap-dependent 
and IRES dependent ribosome recruitment on cellular mRNAs may well be highly 
regulated. 
1.4 eiF4A and DEAD-box RNA Helicase 
Most aspects of RNA metabolism in eukaryotes, bacteria and many viruses 
involve RNA helicases of the superfamily 2, ubiquitous enzymes that use ATP to 
bind and remodel RNA and RNA protein complexes (56, 57). DEAD-box proteins 
share highly conserved amino acid sequence motifs and are involved in almost all 
aspects of RNA metabolism, including transcription, ribosomal biogenesis, pre-
mRNA splicing, RNA export, translation, and RNA degradation (56, 58-60). The 
name of the family was derived from the amino-acid sequence D-E-A-D (Asp-Glu-
Ala-Asp) of its Walker B motif (Figure 4). Many of these DEAD-box proteins have 
been shown to have RNA-dependent ATPase and ATP-dependent RNA helicase 
activities (61, 62). 
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Figure 4-Structure of DEAD box proteins. (A) Classification of DNA/RNA 
helicases. (B)Conserved Sequence Motifs of DEAD-box RNA Helicases. Motif II (Walker B) 
contains the amino acids DEAD in DEAD box RNA helicases. The Q motif is specific to the 
family of DEAD box proteins. RNA helicases share conserved sequence motifs that are 
located in two different domains: motifs I, Ia, Ib, II, and III in domain 1 and motifs IV, V, and 
VI in domain 2. The functions of motifs I (Walker A) and II (Walker B) are required for 
NTP f ATP binding and catalyze its hydrolysis. Motif III has been suggested to couple ATP 
binding and hydrolysis to helicase activity. Motifs Ia, lb, IV, and V bind the substrate RNA. 
Figure adapted from (63). 
The DEAD-box proteins were first identified as a distinct family in the late 
1980s when alignments based on eight homologues of the yeast eiF4A translation 
initiation factor highlighted the presence of several conserved motifs (63, 64). Since 
then, the motifs characteristic of DEAD-box proteins have been found in more than 
500 proteins. However, in the last decades less than 10 crystal structures of 
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helicases have been crystallized. Moreover, only several DEAD-box proteins have 
been crystallized with a RNA substrate (65-67) due to the flexible linker that 
connects the two domains. In addition to the limited structural information, only a 
few DEAD-box proteins have been studied extensively biochemically (38, 68-74) . 
Therefore, unraveling the molecular mechanism of elF 4A activity is particularly 
important for the understanding of the functions of the DEAD-box family helicases. 
As for all helicases, RNA duplex unwinding by DEAD-box proteins is a multi-
step ATP-dependent process. However, DEAD-box helicases employ an unwinding 
mechanism that differs from the translocation-based strand separation observed for 
many DNA and some viral RNA helicases (75-78) . Instead of moving along one of 
the RNA strands, it is suggested that DEAD-box helicases load directly to the duplex 
and then pry the strands apart in an ATP-dependent fashion. This unwinding mode 
is termed local strand separation, since the enzymes separate only several 
(estimated 5 to 7) basepairs per ATP-dependent unwinding event (74). Unwinding 
of longer or more stable duplexes becomes dramatically slower, and virtually no 
unwinding is seen for duplexes with more than two helical turns (59, 79, 80) . 
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1.5 Single-molecule Forster Resonance Energy Transfer (smFRET) 
A 8 
c D 
Figure 5 -Single-molecule techniques used to study helicase function. (A) Total 
Internal Reflection (TIR) smFRET: smFRET is used in surface-tethered assays such that 
dsNAs are specifically attached to a surface via biotin-streptavidin interaction. (B) 
Confocal smFRET: single helicase molecules can be dual labeled with donor and acceptor, 
and cofactor-induced conformational changes can be monitored by confocal microscopy of 
individual diffusing molecules. (C) Optical tweezers: optical tweezers offer the highest 
resolution and are most commonly used with a hairpin substrate to probe helicase activity. 
The dsNA hairpin is tethered between a microsphere and a surfacejmicrosphere. (D) 
Magnetic tweezers: alternatively magnetic tweezers can directly apply a force on an RNA or 
DNA hairpin substrate and thus assist the helicase in opening of the duplex. dsNA opening 
is measured using light microscopy to follow microsphere height above the surface. Figure 
adapted from (81). 
To date, a large body of knowledge on helicase structure, substrate 
specificity, kinetics and mechanisms of unwinding has been obtained through 
structural and ensemble-level studies (56, 57, 77, 82, 83). Among the most widely 
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used techniques for measuring unwinding in bulk are gel electrophoresis-based 
monitoring of complete unwinding of radioactively labeled nucleic acid substrates. 
These assays have helped elucidate helicase functional properties regarding 
substrate specificity and steady-state kinetic parameters (7 4, 80). More recently, 
single-molecule approaches have been applied to probe mechanistic details and 
heterogeneity of helicase action that are undetectable by ensemble-averaged 
measurements (84, 85). Figure 5 summarizes the single-molecule techniques that 
have been applied to helicase studies (81). 
Single-molecule FRET reports on dynamical changes in the distance between 
two fluorophores. Since the first measurement of FRET between a single donor and 
acceptor (86), smFRET has been applied to study conformational dynamics of 
proteins and nucleic acids, as well as protein and RNA folding (87-90). In FRET, a 
donor dye transfers energy to an acceptor dye, and the donor intensity decreases 
and the acceptor intensity increases as the two dyes approach each other. It is 
sensitive to sub-nanometer distance changes in the range of 2-8 nm (Figure 6). 
Excitation energy of the donor is transferred to the acceptor via a dipole- induced-
dipole interaction. Because of this strong distance dependence, structural changes of 
biomolecules or relative motion and interaction between two different molecules 
can be detected via FRET. The high spatia-temporal resolution provided by smFRET 
has been useful in elucidating DNA translocation and unwinding mechanisms of 
Escherichia coli Rep helicase (91) and hepatitis C virus NS3 helicase (92). 
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Figure 6 - Forster resonance energy transfer (FRET). FRET efficiency, E, as a 
function of inter-dye distance (R) for a RO = 50 A. Donor dye directly excited with incident 
laser either fluoresces or transfers energy to acceptor dye, depending upon its proximity. 
Conformational dynamics of single molecules can be observed in real time by tracking FRET 
changes. (93) 
A major advantage of single molecule techniques is the lack of averaging over 
large populations of molecules. Without the need for triggering or synchronization, 
time trajectories of donor and acceptor fluorescence reveal the dynamics of inter-
conversion of different conformations (93). Therefore this method is ideally suited 
to reveal conformational changes in enzyme catalytic cycles. 
Single-molecule FRET experiments on freely diffusing biomolecules is 
performed using an inverted confocal microscope with laser excitation and high-
sensitivity detection (94). The laser beam is focused into a small spot, the confocal 
volume, by an objective. Diffusion of fluorescent molecules through this confocal 
volume leads to excitation and emission of fluorescence bursts. The emitted light is 
collected through the same objective, separated from the excitation light by a beam 
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splitter, split into donor and acceptor contributions using a second beam splitter, 
and detected by highly sensitive avalanche photodiodes (APD). FRET efficiencies 
from many single bursts are plotted in FRET histograms to identify conformational 
subpopulations. The sequence of conformational states and the kinetics of their 
inter-conversion are derived from time-trajectories and dwell time histograms, 
respectively. 
In smFRET experiments using a confocal microscope, the observation time is 
limited by the diffusion time of the molecule through the confocal volume of the 
microscope (89, 95, 96) . For reactions on longer time scales, the observation time 
can be increased by using total internal reflection (TIR) microscopy with fluorescent 
molecules immobilized on the cover slip. Total internal reflection at the cover 
slip/sample interface leads to an evanescent field in the sample. The light intensity 
decreases exponentially with increasing distance from the cover slip surface. Thus, 
molecules close to the surface are selectively excited. Fluorescence from single 
molecules is collected through the objective, and imaged onto an EMCCD camera. In 
TIR setup, the observation time is only limited by photo bleaching of the fluorescent 
dye, and conformational dynamics on the lOOms time scale can be studied. 
Total internal reflection fluorescence (TIRF) microscopy enables the 
excitation of fluorophores in an aqueous solution near a solid interface ( <200 nm). 
This method results in images with very low background fluorescence, which 
enables single molecule fluorescence detection. This thin layer of illumination above 
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the interface is referred to as an 'evanescent field', for which the excitation intensity 
exponentially decays perpendicularly from the surface (97). This 'evanescent field' 
is generated when an excitation light beam traveling in one medium is incident at a 
high angle, 8, upon a second medium and the excitation beam is completely 
internally reflected. The angle at which this total internal reflection (TIR) occurs is 
referred to as the critical angle. When the angle of incidence is greater than the 
critical angle, all the light is reflected back into the first medium. Some of the 
incident energy, however, penetrates through the interface and propagates parallel 
to the surface. Assuming an infinitely wide beam, the evanescent field decays 
exponentially perpendicular to the surface, 
I(z) = I(O)e -z;d 
where I(z) represents the intensity at a perpendicular distance z from the interface 
and 1(0) is the intensity at the interface. The characteristic penetration depth d at A.o, 
the wavelength of incident light in a vacuum, is given by: 
d= 4rrj(n~ sin2 8-nD . 
The refractive index of medium of lesser refractive index is n1, and the 
refractive index of medium of high refractive index is nz. 
Chapter 2 covers the experiments of helicase activity using both bulk and 
sing\e-molecule FRET assays. We want to understand how the helicase activity of 
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eiF4A is stimulated by cofactor e1F4H at the single molecule level. Then we studied 
the interaction between eiF4A/eiF4H complex and RNA hairpins with different loop 
size. We further explored the role of ATP hydrolysis in the unwinding activity of 
eiF4A. The work has been published in (98). 
Chapter 3 focuses on applications of single-molecule FRET towards 
understanding the conformational dynamics in eiF4A during RNA unwinding. We 
labeled several well chosen mutant eiF4A with donor and acceptor and investigate 
the inter-domain and intra-domain distance change by sm-FRET. The sm-FRET 
measurements were performed both on freely diffusing molecules with a confocal 
microscope and on immobilized molecules with a Total Internal Reflection (TIR) 
microscope. To study the interaction of eiF4A with eiF4H, we truncated the full-
length eiF4A into N-terminal domain of eiF4A (eiF4A-NTD) and C-terminal domain 
of eiF4A (eiF4A-CTD). 
In Chapter 4 we describe studies of regulation of eiF4A helicase activity using 
small molecule hippuristanol and RNA aptamer. We want to address the structure 
basis how hippuristanol inhibits the helicase activity of eiF4A. It is known RNA 
aptamer is screened by the affinity of eiF4A. By measuring the inter-domain and the 
intra-domain distance change, we want to investigate how the conformation of 
eiF4A changes upon binding to RNA aptamer. We further want to understand 
whether eiF4H can also interact with RNA aptamer because of its rich secondary 
structure. 
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Finally chapter 5 concludes the thesis by proposing a general mechanism 
how eiF4A/eiF4H interacts with the 5' UTR of mRNA based on our experiment 
results. Then we discuss several open questions which need to be answered in the 
future. 
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Chapter 2: Helicase activity of e1F4A 
2.1 Introduction 
Helicases separate double-stranded nucleic acids into the single-stranded 
intermediates needed for many cellular processes (56, 99, 100). These enzymes are 
considered motor proteins due to their ability to unwind double stranded nucleic 
acids using the energy released from ATP hydrolysis. To understand their 
mechanism at the most fundamental level, one would like to measure real-time 
structural changes of a helicase-DNA/RNA complex during each reaction step. 
Single-molecule techniques in particular, fluorescence resonance energy transfer 
(sm-FRET) are promising for this goal because they can detect the conformational 
changes and biochemical reactions of individual molecules with milliseconds time 
resolution under biologically relevant solution conditions (91, 101-104). 
DEAD-box helicases catalyze the ATP-dependent unwinding of RNA duplexes. 
eiF4A is the prototypical member of the DEA(D/H)-box RNA helicase family. 
Although eiF4A has been extensively studied using classical biochemistry 
approaches (105-107), the mechanisms underlying its ligand-dependent 
conformational changes, its helicase activity as an individual unit, and its significant 
activity enhancement in the presence of eiF4H, have remained elusive. Moreover, a 
direct and unambiguous measurement of eiF4A's position on the mRNA template 
during RNA unwinding has not been reported. Bulk studies of eiF4A helicase activity 
have classically used gel electrophoresis oligonucleotide displacement assays, which 
22 
only detect the completely unwound products and have not provided insight into 
unwinding dynamics. In contrast, sm-FRET can provide direct and highly 
quantitative accounts of eiF4A location and re-positioning on its RNA substrate 
during unwinding, and is well suited to eiF4A's mechanism of action. 
2.2 Results 
2.2.1 Characterization of eiF4A activity using ensemble FRET assay 
To characterize the RNA helicase activity of eiF4A, Cy3-labeled double-
stranded RNA/DNA substrates were used for a fluorophore-based gel assay (Figure 
7). This substrate consisted of 44 nucleotide-long DNA strand hybridized to a 
labeled 15 nucleotide-long complementary RNA, leaving at the 3' end a 29 
nucleotide-long single-stranded overhang. The unwinding activity was evaluated by 
electrophoretic mobility shift assays (EMSA) in native polyacrylamide gels (PAGE) 
by detecting the Cy3-labeled RNA strand as single or double-stranded species. For 
the assay, all reactions were incubated with the RNA/DNA duplex at 35 oc for 1 
hour. In a reaction mix containing the same components but in the absence of ATP, 
the substrate remains mainly as double-stranded form (Figure 7). 
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Figure 7 - Gel assay of eiF4A helicase activity. This native gel assay illustrates the 
degree of unwinding of 15-bp RNA/DNA duplexes with 29 bases long single stranded 
overhang. The short strand (15-mer RNA) is labeled with Cy3. The concentration of the 
duplex is 10 nM. The concentration of ATP is 1 mM for all the helicase assays. The total 
reaction volume is 20 ul. In the absence of eiF4A (Lane 2) or ATP (Lane 3), no unwinding 
activity is observed for eiF4A. When the concentration is more than 2uM in the reaction, 
eiF4A can efficiently unwind the duplex in the presence of ATP (lane 6 and 7). 
To verify that FRET could be used to assess eiF4A helicase activity in bulk, 
we then developed a bulk FRET assay for eiF4A, using an RNA/DNA hybrid 
duplexes. Substrates consisting of 18-mer RNA/DNA hybrid duplexes labeled using 
a FRET pair (Cy3-Cy5) located on opposite strands displayed a stable, high FRET 
level (Figure SA). Upon addition of lmM ATP and increasing concentrations of 
eiF4A, we observed a gradual decrease in FRET signal, followed by a steady lower 
FRET state determined by eiF4A's concentration (Figure SB). The characteristic 
half-life for FRET kinetics was ~3 min. In this assay, we used an extremely low 
RNA/DNA duplex concentration (1 nM) to avoid re-annealing of the two nucleic 
acids strands within the experimental time frame. No FRET change was observed in 
the absence of ATP and the FRET signal was eiF4A concentration dependent (Figure 
SB). 
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Figure 8 -Bulk FRET assay displays an eiF4A-dependent decrease in the steady-
state FRET level. (A) A schematic diagram showing the substrate molecules for bulk 
FRET assay. An 18 base pair RNA/DNA duplex(Tm=51.1 °C, .!lG= -21.4 kcalfmol) labeled 
with a FRET pair introduced at a very low concentration (1 nM) is unwound only in the 
presence of ATP and eiF4A, reaching a lower steady-state FRET level. (B) Results from 
bulk FRET assays monitoring elF4A helicase activity at the indicated eiF4A 
concentrations and 1mM ATP. 
Gel electrophoresis analysis of Cy3-labeled RNA duplexes (Figure 7) showed 
that in the presence of ATP, eiF4A can unwind RNA duplexes, which is in agreement 
with the FRET measurements, and consistent with previous studies (107) . These 
experiments allow us to conclude that increasing eiF4A concentrations leads to an 
increase in unwound RNA/DNA duplexes, although we can make no inferences on 
the linearity of the response from these experiments. 
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2.2.2 Helicase assay of eiF4A using sm-FRET 
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Figure 9 - Schematic of Total Internal Reflection Fluorescence Microscopy 
(TIRFM). (A) Immobilized single molecules are excited by Total Internal Reflection. In 
the objective based TIR excitation, the laser beam used for excitation is focused at the 
back focal plane of the high numerical aperture (NA) objective. Fluorescence is collected 
using the objective. The collimated image is split into the donor and acceptor emissions 
and imaged side by side on the electron-multiplying charge-coupled device (EMCCD). (B) 
By exciting an area around 65um x 65um, 80-100 molecules are imaged in parallel. (C) 
Representative single-molecule FRET trace show high FRET. 
We next characterized eiF4A helicase activity using sm-FRET. Single-
molecule measurements were performed using a homemade microfluidic chamber 
equipped with inlet and outlet flow tubing as described in Figure 9. 
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Initial attempts to use hybrid duplexes of the type shown in Figure 8A as 
substrates were found to be ineffective for sm-FRET since following unwinding of 
the duplexes by eiF4A, non-biotinylated strands (carrying either the donor or the 
acceptor dye) diffused away from the coverslip surface resulting in loss of FRET 
signal. Hence, we developed a series of RNA/DNA hybrid hairpin structures in which 
we designed loops of various sizes, ranging from 3 to 12 nt long (a hairpin molecule 
with a 12-nt long loop is shown schematically in Figure lOA). All the hairpin 
substrate molecules used in this study have LlG values within the range of -16 to -15 
kcalfmol (Figure 21) should be completely unwound by eiF4A according to Figure 7 
and previous reports (80) . The loop structure facilitated multiple observations of 
repeated unzippingjre-annealing kinetics for the same molecule. Figure lOB 
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Figure 10 - sm-FRET recordings of hairpin substrates in the presence of eiF4A. 
(A) Schematic diagram illustrating DNA/RNA hairpin substrate harboring a 12-nt loop 
and 12-bp duplex region, labeled with a FRET pair (Cy3-Cy5). The substrate is 
immobilized to a glass surface via the 3'-end biotin. (B) sm-FRET of the immobilized 
RNA/DNA hairpin in the presence of eiF4A, displaying episodes consisting of decreased 
FRET signals followed by return to original values. (C) FRET distribution from individual 
sm traces (N=38 out of 1000) showing two distinct peaks at 0.9 and 0.6. 
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displays a representative sm-FRET time-trace of the donor (Cy3 green line, Io) and 
acceptor (CyS red line, lA) intensities and their corresponding FRET value 
(IA/(Io+IA), blue line) as a function of time. When both ATP (1mM) and eiF4A (2 uM) 
were added, rare but distinct episodes of FRET transitions were observed, 
characteristically moving from an initial FRET value of 0.90 (corresponding to a 
closed hairpin structure) down to a value of 0.60, then returning to 0.90. Statistical 
analysis was performed on a set of 1000 individual molecules, all of which exhibited 
stable donor and acceptor emission for a minimum of 2 min. We found that traces 
containing at least one FRET transition of any magnitude composed only 3.8% of all 
traces. This subset of events was used to construct a histogram of FRET values that 
displays two clear peaks at FRET levels of 0. 9 and 0.6, corresponding to two well-
defined FRET states that can be approximated by a double Gaussian fit (black line; 
Figure 10C). 
Photophysical effects could be ruled out as the source of the FRET transitions 
for two reasons: (i) Control experiments showed that in the absence of either ATP or 
eiF4A no FRET transitions were observed (Figure 11). (ii) It is well established that 
fluorophore 'blinking' involves complete 'switching off of one of the dyes, rather 
than a transition to an intermediate FRET level. We observed that even at low FRET 
values we still detect substantial photon emissions from both dyes (Figure 10), 
making it unlikely that these transitions are caused by photophysical effects. 
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Figure 11- Single molecule FRET control measurements (lacking either eiF4A or 
ATP). (A) DNA/RNA hairpin substrate with a 12-nucleotide long loop, labeled with a 
FRET pair (Cy3-Cy5). The hairpin molecule is immobilized to the surface via the biotin on 
the single-stranded overhang. (B) Representative single-molecule time trace of the 
hairpin molecule shown in (A): the donor (green line, lo ) and acceptor (red line, lA ) 
intensities and their corresponding FRET value (blue line, calculated as: lA /( lo + lA ) 
are shown as a function of time. When eiF4H and ATP (without eiF4A) are introduced at 1 
11M and 1 mM concentrations, respectively, a steady FRET value is measured, indicating 
the absence of unwinding activity. N > 500 traces. (C) No FRET fluctuation is detected in 
the presence of 1 11M eiF4A/eiF4H when ATP is omitted from this reaction. N > 500 
traces. 
2.2.3 Repetitive unwinding is induced in the presence of eiF4H 
Next, we assessed the consequences of eiF4H on the unwinding parameters 
of eiF4A, given that previous bulk studies have reported elevated eiF4A ATPase 
activity in the presence of eiF4H (38, 108), as well as a stimulation of helicase 
activity (38, 109). The addition of 1 uM eiF4H to eiF4A (at a 1:1 ratio) into the 
single-molecule assay produced a striking change in the FRET dynamics. The FRET 
levels repeatedly and rapidly varied between two discrete values (0.9 and 0.4) for 
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periods lasting several minutes (Figure 12A). Moreover, in sharp contrast to the 
isolated FRET transitions caused by eiF4A alone (Figure lOB), the oscillating two-
level transition pattern for the 12-base hairpin loop accounted for >50% of all sm 
traces in a population of more than 2000 molecules. Since the transitions in FRET 
value from 0.9 to 0.4 (Figure 12B) reflect roughly a 3nm change in donor-acceptor 
distance (approximately the length of the elF 4A dumbbell configuration at its widest 
point) (110, 111) , and given that the FRET transitions are ATP-dependent, the 
results are consistent with previous results that eiF4H, which does not possess 
inherent helicase activity, stimulates the unwinding activity of eiF4A. 
The eiF4AjeiF4H complex leads to reversible unwinding of structured RNA, 
while simultaneously preventing fast re-annealing of the RNA template. Each 
oscillation of the FRET trace between the high and low level represents a single 
unwinding cycle. A Hidden-Markov Model (HMM) analysis (112) of the observed 
two-state fluctuations was used to extract the dynamics of this process, 
characterized by 'waiting time' (high FRET level) and 'unwinding time' (low FRET 
level). Statistical analysis of thousands of these transitions revealed exponential 
distributions of the dwell times for each state, where the characteristic unwinding 
time was found to be Tu =0.71±0.02 sand the characteristic waiting time was found 
to be Tw =1.35±0.05 s (Figure 12C and 12D). 
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Figure 12 - sm-FRET recordings of hairpin substrates in the presence of 
eiF4A/eiF4H. (A) A representative sm time trace of an RNA/DNA hairpin structure 
(schematic illustration in Figure 10). eiF4A/eiF4H are introduced at a concentration of 
luM and ATP concentration is lmM. Donor (In) and acceptor (lA) intensities (green and 
red, respectively) are measured and the corresponding FRET trace is calculated by: lA 
/(lA + ln)(blue). (B) Histogram of FRET levels obtained from N>2000 individual 
molecules under the same conditions as in A, showing two prominent peaks at 0.9 and 
0.4. The oscillating FRET behavior is observed in over 50% of the sm events and is ATP 
dependent. (C) and (D) Dwell times of the low- and high-FRET states are used to 
construct the time histograms of the unwinding time and waiting time intervals (blue and 
green, respectively). Single exponential models are used to fit the data, yielding the 
characteristic timescales Tu and Tw. 
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The fraction of repetitive unwinding traces of elF 4A is dramatically increased 
by eiF4H, therefore, we hypothesized that the possible mechanism that eiF4H 
enhance the activity is by increasing the binding affinity of eiF4A to the substrates. 
To confirm that the repetitive unwinding traces were due to eiF4A/eiF4H complex 
rather than eiF4H alone, two single-molecule experiments were performed. With 
eiF4H and ATP buffer, no unwinding activity is observed in a population of 
hundreds of single-molecule traces (Figure 13A). Then we removed the free eiF4H 
in solution with SX volume buffer wash. Then we flew eiF4A and ATP buffer in the 
channel. Surprisingly we still observed ~15% traces show repetitive unwinding 
even after lOX cell volume wash of eiF4A buffer(Figure 13B). This result 
unequivocally demonstrates that eiF4H enhances eiF4A helicase activity by 
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Figure 13 - eiF4H enhances eiF4A helicase activity by increasing the RNA 
binding affinity (A) Representative single-molecule traces with eiF4H and ATP buffer. No 
helicase activity of eiF4H was observed in the presence of ATP. N > 500 traces. (B) 
Repetitive unwind traces after 5X volume buffer wash and then reintroduce eiF4A and 
ATP buffer. N > 500 traces. 
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increasing the RNA binding affinity and the binding of eiF4H to RNA substrate is 
independent of eiF4A. 
2.2.4 Single eiF4AfeiF4H is responsible for the repetitive unwinding 
To exclude the possibility that the observed FRET transitions stem from 
binding/unbinding events of multiple eiF4A/eiF4H complexes to the nucleic acid 
substrates, we monitored the FRET activity (in the presence of eiF4A, eiF4H and 
ATP) for a set of substrate molecules, followed by flushing the flow cell with more 
than 5 volumes of buffer lacking eiF4A, eiF4H or ATP and monitoring FRET activity 
for 60 s (Figure 14). This treatment, which resulted in a loss of FRET fluctuations 
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Figure 14 - eiF4A/eiF4H complex remains bound to the hairpin substrate during 
cycles of repetitive FRET signal oscillations. A typical FRET trace for a single substrate 
molecule acquired in reactions containing: (A) both eiF4A, eiF4H (1 uM) and ATP (1 mM); 
(B) after>S_volume flushing of the chamber with buffer lacking eiF4A, eiF4H and ATP 
'Wash 1' ; C followin reintroduction of onl ATP at 1mM 'Wash 2' . 
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(Figure 14B), was then followed by re-introduction of only ATP into the system. We 
noted a resumption of repetitive FRET fluctuations (Figure 14) for the majority of 
the observed single molecules (some molecules were either photo-bleached during 
the process or washed away). These results indicate that the FRET activity observed 
after ATP reintroduction is due to the presence of eiF4A/eiF4H proteins that have 
remained bound to the duplex strand during all washes. Taken together with the 
results above illustrating that the observed repetitive FRET transitions are ATP-
dependent and reflect a change in donor-acceptor distance of -3 nm, they most 
likely result from an oscillatory unwindingjre-annealing pattern of the same eiF4A/ 
eiF4H complex that remained bound to its substrate. 
2.2.5 The eiF4A/eiF4H complex binds to the loop region of hairpins 
To further evaluate the stimulatory role of eiF4H on eiF4A unwinding 
dynamics, we explored how substrate design could affect eiF4A activity. It has been 
reported that eiF4A unwinds RNA substrates with single-strand overhangs slightly 
more efficiently than blunt ended RNA duplexes (80) . By analogy, we speculated 
that eiF4H facilitates duplex unwinding activity of e1F4A by binding first to single-
stranded portions of the RNA. This would serve two goals, both increasing the 
affinity of the eiF4AjeiF4H complex for single-stranded domains of the RNA 
transcript as compared to the affinity of eiF4A alone for such substrates, and also 
allowing for a more processive unwinding mechanism. 
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Figure 15 - Repetitive RNA hairpin unwinding persists when the single 
stranded overhang is blocked. (A) The single stranded overhang in the hairpin 
molecules was "blocked" by hybridization of a matching 23 nts. long oligo. (B) 
Repetitive sm-FRET fluctuations were observed with the "blocked" molecule. The 
frequency of the repetitive fluctuations were nearly identical in terms of fraction of 
events showing the fluctuation patterns in each run, and their time-scales, to a similar 
construct but without the blocking oligo. 
The preferred binding location of the eiF4AjeiF4H complex to the RNA 
substrates used in these experiments was determined by two sm-FRET 
experiments. First, a complementary DNA oligonucleotide located adjacent to the 
biotin residue was used to block the single-stranded portion of the RNA substrate 
(Figure 15). For these 'blocked' samples, repetitive FRET fluctuations were 
observed and persisted to the same extent as reported above, indicating that a 
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single-stranded overhang does not contribute significantly to eiF4A/eiF4H's 
repetitive unwinding capability. 
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Figure 16 - eiF4A/eiF4H complex requires hairpin substrates containing 
minimum loop sizes of 6 nt for repetitive unwinding. The fraction of sm traces showing 
more than 3 oscillations in a 60 s monitoring time window is plotted as a function of 
loop length (in nucleotides). Each data point consists of at least 1500 sm traces. 
Next, under the assumption that eiF4H must preferentially bind to the loop 
region, we addressed whether a critical length is involved in the interaction of the 
eiF4A/eiF4H and its RNA hairpin substrate. We tested substrates with different 
loop sizes, ranging from 3 to 12 nt long. In each of these experiments, we collected at 
least 1500 sm traces and calculated the fraction of traces displaying the oscillating 
FRET pattern in each experiment. The results indicate that FRET oscillations are 
practically non-existent when the loop size is shorter than 6 nt (Figure 16). 
Furthermore, the FRET assays showed a distinct increase in the percent of substrate 
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molecules undergoing oscillations for longer loop sizes, reaching -65% when the 
loop size is 12 nt long. The results suggest that the critical minimum loop size 
required for the eiF4A/eiF4H complex to bind and initiate repetitive unwinding 
activity upon an RNA substrate is 6 nt. 
2.2.6 The repetitive unwinding involves a single ATP hydrolysis per cycle 
To explore the role of ATP hydrolysis in the repetitive unwinding process, we 
reduced the ATP concentration from 1mM down to 30 mM and measured the 
resulting sm-FRET dynamics (Figure 17). If the 'waiting time' Tw, represents the 
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Figure 17 - Dependence of the hairpin substrate unwinding dynamics by the 
eiF4A/eiF4H complex on ATP or ATP-yS concentrations. In these experiments, 12-nt 
hairpin loop structures were used, and 1 uM of both eiF4A and eiF4H. (A) Relationship of 
the waiting times ( Tw, circles) and the unwinding times ( Tu, triangles) on the ATP 
concentration. Each data point represents statistics of at least 1000 sm traces (detailed 
distributions are provided in Figure 18 and Figure 19). (B) The dependence of waiting 
times (Tw, circles) and unwinding times (Tu, triangles) on the relative ATP-yS 
concentration, with a fixed ATP concentration of 0.1mM. The abscissa x 
=[ATPyS]/[ATP+ATPyS]. Each data point represents statistics of at least 500 sm traces. 
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time required for the recruitment of a fresh ATP molecule from bulk, then reducing 
ATP concentration to the point where ATP diffusion time becomes the rate-limiting 
step is expected to affect Tw but not 'unwinding time', Tu. This prediction is 
confirmed by our data. A 60% increase in Tw (circles) was observed upon reduction 
of the ATP concentration below 0.1mM, whereas the unwinding time (triangles) 
remained unaffected (Tu =0.64±0.15 s) for all ATP concentrations measured (the 
dwell-time distributions for each data point are shown in Figure 18). Moreover, the 
fact that Tu does not increase upon a decreasing the ATP concentration, while Tw 
does increase, suggests that a single ATP molecule is consumed per unwinding cycle 
since consumption of two or more ATP molecules per cycle would have resulted in a 
concurrent increase in Tu when the ATP concentration falls below "'0.1mM. 
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Figure 18 - Dependence of FRET dynamics on ATP concentration. The dwell times of the 
two levels of FRET oscillations were extracted using Hidden Markov Modeling and their 
corresponding distributions at different ATP concentrations ranging from 30!1M to lmM 
are shown. The characteristic unwinding time (blue bars) and waiting times (green bars) 
were evaluated using single-exponential least-squares fits to the data (red lines). 
Numerical fits to extract the timescales and errors were performed using Igor Pro 
(WaveMetrics, Inc.). 
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Figure 19 - Dependence of sm-FRET dynamics on the relative concentration of the non-
hydrolysable ATP analog, ATP-yS. The dwell times of the two FRET oscillations levels 
were extracted using Hidden Markov Modeling and their corresponding distributions as a 
function of ATP-yS concentration, using a fixed total concentration [ATP]+[ATP-yS] = 
O.lmM. The characteristic unwinding time (blue bars) and the waiting times (green bars) 
were evaluated using single-exponential least-squares fits to the data (red lines). 
Numerical fits to extract the timescales and errors were performed using Igor Pro. 
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We also tested whether or not the poorly hydrolysable ATP analog, ATP-yS, 
could substitute for ATP in the unwinding reaction (Figure 17). By keeping the total 
concentration of [ATP]+[ATP-yS] fixed, we found that increasing the fractional 
amount of ATP-yS up to 15% had little effect on the waiting time or the unwinding 
time (the dwell-time distributions for each data point are shown in Figure 19). 
However, we find that both the fraction of sm traces showing consecutive sm-FRET 
oscillations within a fixed 60 s monitoring interval, as well as the average number of 
repetitive FRET cycles observed for any given molecule, displayed a 3- to 4-fold 
decrease with increasing x values (Figure 20). This experiment suggests that ATP-
yS can substitute for ATP in the initial eiF4A/eiF4H complex formation, but 
irreversibly terminates the FRET oscillations since these require a hydrolytic event. 
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Figure 20 - Dependence of the fraction of oscillating traces and number of 
transitions on ATP-yS concentration. Top panel: The fraction of single-molecule traces 
showing at least 3 consecutive sm-FRET oscillations within the 60 sec monitoring 
interval, as a function of the relative ATP-yS concentration: 
X = [ATP-rS]/[ ATP ]+[ ATP-yS]. At least 500 transitions were analyzed for each data 
point. Bottom panel: The average number of repetitive FRET cycles as a function of x. In 
these experiments the total concentration of [ ATP ]+[ATP-rS] was held fixed at 0.1 
mM. At least 500 transitions were analyzed for each data point. 
2.3 Conclusions and Discussion 
Single-molecule approaches can be used to directly quantify a variety of 
biomolecular processes, providing observational access to, and information about, 
their detailed dynamics under physiological conditions, especially when used in 
combination with classical biochemical assays. Here, we utilized sm-FRET to probe 
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the unwinding dynamics of eukaryotic initiation factor eiF4A in the presence of the 
RNA binding cofactor eiF4H. We find that eiF4A alone can induce rare and isolated 
unwinding episodes of RNA duplexes. We also use sm-FRET to probe the 
consequences of eiF4H on the unwinding parameters of eiF4A and find that the 
resulting eiF4AfeiF4H complex exhibits an abundance of persistent, repetitive 
cycles of unwinding over extended periods of time. We find that eiF4A is directed to 
bind to single-stranded loop structures by eiF4H, facilitating its ability to 
repetitively unwind duplexes in an ATP-dependent manner. 
Our results indicate that the assembly of the eiF4A/eiF4H complex on the 
RNA hairpin substrate, and subsequent unwinding of its duplex regions can be 
significantly enhanced by long-lived binding of the complex to single-stranded loop 
domains longer than a critical minimum length of 6 nt. In accordance with previous 
studies indicating that eiF4H binds to RNA via the RNA recognition motif (RRM) 
domain, our results support a simple RNA unwinding model, where repetitive 
unwindingjre-annealing cycles can be efficiently executed by the eiF4A/eiF4H 
complex when bound to a loop domain of RNA hairpin. 
Upon ATP hydrolysis, unwinding of the duplex region induces rapid high-to-
low FRET level transitions. This mode of short distance helicase activity is quite 
efficient, consuming a single ATP molecule per cycle of unwinding. The unwinding 
process can be terminated upon binding of the poorly hydrolysable ATP analog, 
ATP-yS. The ATP dependence of the unwinding activity of eiF4AfeiF4H is 
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reminiscent of other DEAD-box helicases such as CYT -19 and DbpA, which have 
been shown to achieve complete strand separation of RNA duplexes via hydrolysis 
of a single ATP molecule ( 69). 
Linking eiF4A activity to eiF4H function establishes a crucial means by which 
eiF4A activity could be regulated. Generally, eiF4H activity involves directing other 
cellular proteins to specific mRNA structures to enhance their activity. For example, 
eiF4H binding is required for the herpes simplex virus (HSV) virion host shutoff 
(Vhs) protein-induced degradation of many mRNAs, where it targets Vhs to 
preferred sites within mRNAs (113). siRNA-mediated depletion of eiF4H, but not 
eiF4B, in HeLa cells impedes Vhs-mediated mRNA degradation (113) . We find that 
eiF4H plays a similar role in stimulating eiF4A activity. 
The marked increase in unwinding activity observed for hairpin substrates, 
as compared to a simple duplex with an overhang, suggests that the eiF4A/eiF4H 
complex binds to hairpin loops with higher affinity than to single-stranded 
overhangs. This configuration allows it to maintain close interaction with both 
strands in order to initiate multiple unwinding episodes, which in turn keeps the 
RNA in its unwound state for a longer total period of time. Another conceivable 
advantage of this configuration is that the eiF4A/eiF4H repeated unwinding activity 
augments downstream steps, ultimately and indirectly stimulating ribosome 
binding, and consequently protein synthesis. The mRNA 5' -UTRs present a complex 
landscape of short stem and loop regions. Our data suggests that if eiF4H could be 
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delivered internally to such loops, in conjunction with eiF4A, RNA remodeling 
should rapidly occur. This might play an important role in IRES-dependent 
translation initiation. 
2.4 Materials and Methods 
2.4.1 RNA/DNA substrate preparation 
DNA and RNA oligonucleotides were purchased from IDT (Coralville, lA) and 
Dharmacon (Lafayette, CO), respectively. The oligonucleotides were labeled using 
Cy3 or Cy5 (GE Healthcare, Little Chalfont, UK) according to the vendor's 
recommended protocol. Oligonucleotides and dyes were mixed at a molar ratio of 
1:15, respectively. The conjugation included incubating samples overnight in 0.1M 
sodium tetraborate buffer (pH 8.5) at room temperature. Conjugation was 
confirmed using native polyacrylamide gel electrophoresis (PAGE) and quantified 
by UV-Vis absorption. RNA/DNA hybrid duplexes were formed by annealing the 
oligonucleotides in 50mM Tris-HCl (pH 7.5), 0.2mM EDTA and 500mM NaCI, 
heating the samples to 95°C, and slowly cooling them to 4°C over a period of 2.5 h. 
The duplexes were then purified using native PAGE. 
Hybrid hairpin structures were prepared by mixing DNA oligonucleotides, 
which contained a loop region, with single-stranded RNAs. The DNA 
oligonucleotides contained a terminal biotin moiety used for surface immobilization 
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in the sm assays. Ligation of the DNA/RNA strands was performed with T4 RNA 
ligase 2 (New England Biolabs, Ipswich, MA), following which substrates were 
purified by denaturing PAGE to remove the unligated oligonucleotides. The 
preparation of a blunt-ended I:tairpin substrate was performed by mixing the 
purified hairpin sample with an additional oligonucleotide (23 nt ssDNA) at a 
hairpin:ssDNA molar ratio of 1:10, heating to 95°C, and allowing to slowly cool to 
4°C over a period of 2.5 h. The blunt-end hairpin was purified using native PAGE. 
The sequences of all oligonucleotides used in this study are shown in the Figure 21. 
A) 18bp RNA/DNA(Delta G = -24.7 kcaljmole) duplex used in Figure 8. 
5
' A G AU C U G U C U G C A G U A GC1 
I I I I I I I I I I I I I I I I I I 
TC T AGACAGACGT1CA T CGA T A(CAAAA)4G-biotin 5, 
B) RNA/DNA hairpin with a 12nt loop ( 1:1G = -14.9 kcalfmole), used in Figures 10-
14. 
,;r .... c ... rc f GTCUGCAGUAGC1 5' C I I I I I I I I I I I I . 
, CAGACGT1CATCGAT AACAA(CAAAA)3C-blotin3' 
T'c-r-<YT/ 
C) Blunt-ended RNA/DNA hairpin with a 12nt loop ( 1:1G = -14.9 kcaljmole), used in 
Figure 15. 
C,;r..-c---r 'c / s T G T c u G c A G u A G C1T A T T G T T(G T T T T)3 G 5' 
I I I I I I I I I I I I I I I I I I I I I I I I I C{ CAGACGT1CA TCGA T AACAA(CAAAA)3C-biotin 3' 
T'c-r_c,...T/ 
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D) RNA/DNA hairpins with 3nt (.1G = -15.1 kcaljmole), 4nt · (.1G = -15.9 
kcaljmole), 5nt (.1G = -16.4 kcaljmole), 6nt (.1G = -15.4 kcaljmole), or 9nt (.1G 
= -15.4 kcaljmole), loops, used in Figure 16. 
1 T'GT C UGCAG UAGC1 5' 
C I I I I I I I I I I I I 
"T...-CAGACGT1CATCGATAACAA(CAAAA)3C-biotin 3• 
T ..... c'GT C UGCAG UAGC1 5' 
I I I I I I I I I I I I I 
C CAGACGT1CATCGATAACAA(CAAAA)3C-biotin 3. 
'T/ 
,c ..... TGT C U GCAG UAGC1 5' 
T I I I I I I I I I I I I 
'c CAGACGT1CA T CGA T AACAA(CAAAA)3C-biotin 3' 
-T/ 
crCGT C UGCAGUAGC15' 
I I I I I I I I I I I I I 
1:_ CAGACGT1CATCGATAACAA(CAAAA)4C- biotin3• 
c, T/ 
f ...-T-C-TG TC UGCAG UAGC15' I I I I I I I I I I I I . 
'c CAGACGT1CA T CGA T AACAA(CAAAA)3C-blotin 3' 
'T-C-T/ 
Figure 21 - RNA/DNA sequences and modifications. In all sequences, C1 is 
the amino (6-carbon) linker (for labeling with Cy5) and T1 is the internal amino 
modifier C6 dT (for labeling with Cy3). HyTher (114) and Mfold (115) are used to 
calculate the .1G values of all substrates, at 25 °C, 100 mM Na+, and 2 mM Mg2+. 
2.4.2 Protein expression and purification 
Recombinant His6-eiF4A and His6-eiF4H were expressed in E. coli BL21-
Gold (DE3) cells (Stratagene, La Jolla, CA). Following IPTG-induction of expression, 
lysis of cells by sonication and clearing of the supernatant by centrifugation, His6-
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eiF4A-containing lysate was loaded on a Ni++-Sepharose 6 Fast Flow resin (GE 
Healthcare, Piscataway, NJ). The matrix was washed, eluted with A300 buffer [20 
mM Tris (pH 7.5), 10% glycerol, 300mM KCI, 0.1mM EDTA] containing 0.2M 
imidazole. Following dialysis against A100 buffer [20mM Tris (pH 7.5), 10% 
glycerol, 100mM KCI, 0.1mM EDTA and 2mM DTT], eiF4A was loaded onto a Q-
Sepharose fast flow matrix (GE Healthcare). The resin was washed with 10 column 
volumes of A100 and protein eluted using a linear salt gradient from 100mM to 
500mM KCl in buffer A (20mM Tris (pH 7.5), 10% glycerol, 0.1mM EDTA, 2mM 
DTT). The eluted fractions were analyzed by SDS-PAGE and those containing eiF4A 
were pooled and dialyzed against buffer A 
His6-eiF4H was first enriched on a Ni++-Sepharose column then further 
purified on a Heparin-Sepharose matrix (GE Healthcare). After applying the sample, 
the resin was washed with 1 column volume of A100 containing 2mM DTT, and 
eiF4H eluted with a linear salt gradient from 100 to 500mMKCl in buffer B 
[20mMTris (pH 7.5), 10% glycerol, 0.1mM EDTA and 2mM DTT]. The eluted 
fractions were analyzed by SDS-PAGE and those containing t His6-eiF4H were 
pooled and dialyzed against storage buffer [20 mM HEPES (pH 7.5), 25% glycerol, 
50mM KCI, O.lmM EDTA and 1mM DTT]. 
2.4.3 Bulk FRET assay 
In the bulk measurements, the donor (Cy3) and the acceptor (Cy5) signals 
were collected using a home-build confocal setup as previously described (116). Cy3 
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was excited by a 514.5-nm line of Ar+ laser (Spectra-Physics, Santa Clara, CA). 
Emissions from donor and acceptor channel were discriminated using dichroic 
mirrors (Chroma Technology, Bellows Falls, VT) and measured by two avalanche 
photodiodes (Perkin-Elmer, Wellesley, MA). The exposure time is 1 s and the 
sampling rate is 2 Hz. In all bulk experiments, 1nM of duplex substrate molecules 
were used to minimize re-annealing of the strands upon unwinding. 
2.4.4 Single-molecule FRET assays 
Single-molecule measurements were performed using a homemade 
microfluidic chamber equipped with inlet and outlet flow tubing. The quartz 
coverslip (Esco Products, Oak Ridge, NJ) of the cell was first coated with biotinylated 
BSA (Sigma, St Louis, MO) and then with streptavidin (Thermo, Rockford, IL). 
Biotinylated samples were immobilized on the coverslip through biotinylated BSA-
streptavidin chemistry. 
In a typical experiment, a 10 pM RNA/DNA hybrid hairpin solution was 
flowed through the cell, immobilizing roughly 100 molecules in a single field of 
view of the microscope. In order to remove unattached hybrids, the cell was washed 
10 times with imaging buffer, complemented with an oxygen scavenging system [SO 
mM Tris (pH 7.5), 50mM NaCl, saturated Trolox (>2mM) (Sigma), 5mM 
Protocatechuic acid (Sigma) and 0.15 mM Protocatechuate 3,4-Dioxygenase(Sigma)] 
(117). eiF4A or eiF4A/eiF4H (1:1) complex (1 mM) was incubated with the 
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immobilized hybrids for 10 min at 22°C in imaging buffer containing 1mM ATP 
(Roche Applied Science, Indianapolis, IN, USA) and 1mM MgC12. 
sm data acquisition and analysis The FRET donor (Cy3) and acceptor (CyS) 
signals were collected using a modified objective-type total internal reflection 
(TIRF) microscope (IX71, Olympus, Japan). Cy3 was excited by a S32-nm laser 
(Millennia V, Spectra- Physics, Santa Clara, CA). Emissions from donor and acceptor 
were discriminated using dichroic mirrors (Chroma Technology, Bellows Falls, VT, 
USA) and imaged by an EMCCD camera (iXon DV 897, Andor Technology, Belfast, 
Ireland) at10 framesjs, except where otherwise noted. A custom image acquisition 
program written using LabVIEW (National Instruments, Austin, TX) was used to 
acquire movies and stream data to the computer's hard-drive. sm traces were 
extracted and analyzed using programs written in Matlab (Mathworks, Natick, MA). 
FRET values were calculated as IA/(IA+In), where lA and In are the fluorescence 
intensity of the acceptor and donor channels, respectively, following correction of 
background noise. The two-state FRET oscillations were analyzed using Hidden 
Markov Modeling (HAMMY). 
2.4.5 Bulk helicase assay of eiF4A 
The total reaction volume was 20 ul which contained 10nM RNA/DNA 
duplex, 2 mM ATP, 20 mM TRIS (pH 7.5), SO mM KCI, 2 mM DTT, 2 mM MgCl2, and 
0.1 mgjml BSA. The length of duplex was 1S bp. DNA and RNA oligos were custom-
synthesized and purified by HPLC (Integrated DNA Technologies, Coralville, lA). The 
so 
sequence of the short RNA strand was 5'-GUGCUUUACGGUGCU-3' and the 5' end 
was amine modified for labeling with Cy3. The sequence of the DNA strand was 5'-
GGGAGAAAAACAAAACAAAACAAAACT AGCACCGT AAAGCACGC-3'. The 
concentrations of both wild-type and mutant eiF4A were 2uM. Reactions were 
incubated at 35 oc for 1 hour. Then the reactions were terminated by the addition of 
5ul of a solution containing 50% glycerol, 2% SDS and 20 mM EDT A. The products 
of unwinding were analyzed by electrophoresis on 15% native polyacrylamide (2 9:1 
acrylamide:bisacrylamide) gels for 2 hat 180 Vat 4 oc in lx Tris borate-EDTA(TBE) 
buffer. 
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Chapter 3: Probing conformational change and dynamics of eiF4A 
3.1 Introduction 
The function of many important biomolecules comes from their dynamic 
properties and their ability to switch between different conformations. DEAD-box 
proteins catalyze the ATP-dependent unwinding of RNA duplexes (56, 58, 59, 118, 119). 
The common unit of proteins from DEAD-box super family is a helicase core of two 
flexibly linked RecA domains. In addition to interacting with dsRNA and ssRNA at the 
canonical RNA binding site within the core, some DEAD-box proteins use additional 
RNA interactions to localize the core to the physiological targets (66, 71, 96, 120). 
Crystallographic analyses have revealed structural features that are 
universal to DEAD-box proteins. Several DEAD-box proteins, such as Vasa (67), 
eiF4A-III (65), Mss116p (66), Dbpa (71), CYT-19 (120), and YxiN (96) adopts a 
compact conformation as in the presence of AMPPNP and RNA substrate. ATP 
binding and phosphate release control opening and closing of the conformation of the 
helicase core. This movement coordinates RNA-binding and ATPase activity and is thus 
central to the function of DEAD-box helicases. Molecular features have been 
elucidated for two types of interactions. It is suggested that the C-tail of Mssp116 
and CYT -19 contacts the adjacent RNA and tethers the core for RNA unwinding ( 66, 
120) . A C-terminal domain of Dbpa and YxiN adopts the fold of an RNA recognition 
motif (RRM) and binds specifically to a hairpin structure within the 23S rRNA (helix 
92) (71, 96). The flexible linkage between the RRM domain and the helicase core 
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may permit the RRM domain to form an anchoring interaction while the core 
interacts with nearby RNA structures (121). 
However, conformational dynamics of the DEAD-box proteins remain 
uncharacterized. To illuminate the conformation change of eiF4A during RNA 
unwinding, we labeled several well chosen mutant eiF4A with donor and acceptor 
respectively and investigated both the inter-domain and intra-domain distance 
change in real time by single-molecule Fluorescence Resonance Energy Transfer 
(sm-FRET). Fluorescence intensities from ensembles of molecules naturally reflect 
the averaged intensities from all molecules present. FRET efficiencies determined 
from these intensities thus yield population-weighted averages of individual FRET 
efficiencies in all conformations. Consequently, the distances obtained from the 
conversion of these FRET efficiencies do not reflect intermolecular distances within 
individual molecules. 
The limitation of ensemble measurement can be overcome by smFRET 
studies that provide information about FRET efficiencies of individual molecules, 
and thereby reveal sub-populations (122). Fluorescence intensities of 
donor /acceptor-labeled single molecules diffusing freely in solution can be 
measured by confocal microscopy. In confocal smFRET experiments, each single 
molecule produces a burst of fluorescence while it diffuses through the confocal 
volume with a typical duration of a few milliseconds. The measured fluorescence 
intensities allow the burst-wise calculation of the FRET efficiency for each individual 
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molecule. Histograms of FRET efficiencies for a large number of molecules 
measured one at a time directly provide information on subpopulations and report 
conformational changes(72, 89, 96, 123, 124). Several FRET efficiencies provide 
distance restraints that define global conformations and relative domain 
rearrangements. Although completely free of surface effects, the observation period 
is limited by the molecules' residence time in the laser focal volume, and it is very 
difficult to detect conformational changes that occur in several milliseconds or 
longer time scales (96). For this reason, we need immobilize labeled eiF4A on the 
surface. 
Use of the lipid vesicle nanocontainer is one of the confinement approaches 
where labeled biomolecules are encapsulated inside 50-200 nm lipid vesicles, and 
these vesicles are immobilized on the surface for smFRET measurements. This 
approach combines advantages of the surface tethering and the diffusion based 
approaches. One of the unique advantages with the use of the lipid nanocontainer is 
that due to the confinement of molecules within an attoliter volume (10-18 L), a high 
effective concentration in the several micromolar range is attainable. Such high 
concentration of labeled molecules would give overwhelming background 
fluorescence making both surface immobilization and diffusion based smFRET 
measurements impossible in most cases. The high effective concentration opens up 
a way to study many weakly interacting biological molecules with conventional 
single-molecule fluorescence microscope setup (125) . 
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The use of a small unilamellar vesicle (SUV) as a biomimetic nanocontainer 
has first been demonstrated by encapsulating biomolecules, such as hairpin 
ribozyme (126, 127) and adenylate kinase (128) within egg phosphatidylcholine 
( eggPC) vesicles immobilized on the surface. However, the impermeability of the 
lipid membrane to small ions and molecules has limited the application to studying 
molecules only at the equilibrium with the initial buffer condition. In order to 
overcome the impermeability problem, a unique porous nature of the lipid 
membrane near the gel-fluid phase transition temperature (Tm) has been used 
(129, 130). Dimiristoylphosphatidylcholine (DMPC) is a lipid molecule composed of 
two fourteen carbon chain tails with gel-to-fluid transition temperature near the 
room temperature (Tm = 23 °C). At room temperature, coexistence of gel and fluid 
phases creates mismatches in thicknesses and form transient defects large enough 
for small molecules, such as ions, ATP and ADP, to pass across the membrane, but 
impermeable to slightly larger molecules. Using this property, the real time single 
molecule filament assembly and disassembly of RecA on a single stranded DNA 
(ssDNA) has been reported (129). 
Having established in Chapter 2 that eiF4A/eiF4H complex is able to 
repetitively unwind RNA hairpin, here we focus our efforts on answering the 
structure basis behind this repetitive unwinding. To understand the repetitive 
unwinding, we need the information on conformational changes in eiF4A during 
helicase action. In this chapter, we will describe smFRET investigations that have 
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focused on conformational dynamics of eiF4A. We first described the use of freely 
diffusion confocal setup to monitor conformational changes of double-labeled 
eiF4A. Because the observation time using freely diffusion confocal setup is limited 
to millisecond, we then encapsulated RNA hairpin, eiF4H and labeled eiF4A in a 
porous vesicle and then immobilize the vesicle on the quartz coverslip through BSA-
streptavidin chemistry. This porous vesicle enables us to do buffer exchange (e.g 
ATP and small molecules) during reaction and at the same time eiF4A, eiF4H and 
RNA hairpin are trapped in the nanocontainer. 
3.2 Results 
3.2.1 Bulk helicase activity of mutant eiF4A 
eiF4A + + + + 
ATP + 
ATPyS + 
AMPPNP + 
•• 
Figure 22 - eiF4A helicase activity is ATP dependent. The 
concentration of eiF4A is 2uM. eiF4A alone cannot unwind 15 bp RNA/DNA 
duplex(lane 1). The length of DNA is 44nt. It can almost completely unwind 
RNA/DNA duplex with the energy of ATP hydrolysis (lane2). In the presence 
of a slowly-hydrolyzable analogue of ATP, ATPyS, eiF4A can unwind part of 
the duplex although the efficiency is poor (lane3). Lane 4 shows that eiF4A 
cannot unwind the RNA/DNA duplex in the presence of nonhydrolyzable ATP 
analo ue, AMPPNP. 
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To investigate the conformational changes in the ATP catalytic cycle of the 
eiF4A, we need to label the protein with both donor and acceptor. Thiol-reactive 
dyes are principally used to label proteins for the detection of conformational 
changes, assembly of multisubunit complexes and ligand-binding processes (125, 
131). The primary targets ofthiol-reactive probes are cysteine residues. In order to 
enable site-specific labeling of eiF4A with donor and acceptor, we need to construct 
double-cysteine mutants for inter-domain and intra-domain labeling. The wild type 
(WT) eiF4A contains four intrinsic cysteines at positions 66, 131, 133, and 264. 
Cysteine 66, 131, and 133 are in the amino terminal domain (NTD) of eiF4A, and 
cysteine 264 is in the carboxy terminal domain (CTD). An extra cysteine at position 
403 is generated for the labeling of eiF4A-CTD with both donor and acceptor. 
As shown in Figure 22, WT eiF4A can unwind a 15 bp RNA/DNA duplex in an 
ATP dependent manner. In the presence of nonhydrolyzable analogue of ATP, 
AMPPNP, WT eiF4A cannot efficiently unwind the 15 bp RNA/DNA duplex (Figure 
22). We then investigated whether the mutation interfere with the helicase activity 
of eiF4A. As shown in Figure 23A, all mutants can unwind the 15 bp RNA/DNA 
duplex with yields comparable with the wild type eiF4A, which confirms that all 
mutant eiF4A are functional RNA helicases despite the mutations. 
We then labeled the mutant eiF4As with donor and acceptor. The purities of 
the double-labeled mutant eiF4As were checked using Bio-Rad Experion Pro260 
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protein chip assay following the manufacturer's protocol. The purities of the labeled 
eiF4A are comparable to that ofWT eiF4A (Figure 23B). 
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Figure 23- Helicase activities of wild-type (WT) eiF4A and mutant eiF4A. (A) All 
mutant constructs show similar unwinding yield as WT eiF4A after 60 min of incubation 
of RNA substrate at 35° C in the presence of ATP. Samples were quenched with SDS and 
electrophoresed in a 15% nondenaturing polyacrylamide gel to separate duplex and 
single-stranded RNAs. Positions 1(66aa), 2(131aa) and 3(134aa) in the N-terminal and 
positions 4(264aa) and 5(403aa) in the C-terminal domain of eiF4A were selected for 
generating of double-cysteine mutants (mutant4A-14, 4A-24, 4A-34, 4A-12, and 4A-45). 
(B) SDS-PAGE analysis gel using Bio-Rad Experion Pro260 protein chip assay. The purity 
of each labeled eiF4A (lane 4 to lane 8) is comparable to that ofWT eiF4A (lane 2). 
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3.2.2 Single-molecule helicase assay of mutant eiF4A 
A B 
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Figure 24 - smFRET helicase assay of mutant eiF4A mutant4A-14. (A) 
Schematic diagram of RNA hairpin substrate labeled with both donor and acceptor (B) 
Representative single-molecule FRET trace shows repetitive unwinding of RNA hairpin. 
The concentration of eiF4H is the same as that of eiF4A which is luM. The 
concentration of ATP is lmM. (C) and (D) Analysis of unwinding time Tu and waiting 
time Tw. The mutation does not change the time scale of unwinding kinetics of eiF4A. 
Having shown that all mutant eiF4As show similar bulk unwinding activity as 
WT eiF4A, we next studied whether the time scale of RNA unwinding kinetics is 
changed by the mutation. We then immobilized the RNA hairpin labeled with donor 
and acceptor on the surface and collect hundreds of single-molecule FRET traces in 
the presence of eiF4H, mutant eiF4A and ATP. The single-molecule FRET assays of 
mutant elF4A-14 (Figure 24) show that the eiF4A-14 has similar time scale of 
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unwinding kinetics comparing with that of the WT eiF4A (Figure 12). The 
'unwinding time' Tu is 0.71 +/-0.06 sec and the 'waiting time' Tu is 1.29 +/-0.05 sec. 
3.2.3 eiF4H binds to eiF4A-NTD but not to eiF4A-CTD 
eiF4H has an RNA recognition motif (RRM) that can increase the eiF4A 
affinity for RNA and influence its substrate specificity ( 43, 132). In Chapter 2 we 
have illustrated that eiF4H can significantly enhance the helicase activity of eiF4A 
by binding to loop structures of RNA hairpin as well as to eiF4A. The possible 
mechanism is that eiF4H could stabilize the RNA binding through the RRM and then 
anchor the helicase to its RNA substrate. 
It is known that eiF4A has a 'dumbbell' structure with two globular domains 
connected by a flexible linker (110, 111). Further we want to characterize the eiF4H 
binding sites on eiF4A. We truncated the full-length eiF4A into N-terminal domain 
of eiF4A (eiF4A-NTD, residues 1-244) and C-terminal domain of eiF4A (e1F4A-CTD, 
residues 237- 406) (133) (Figure 25) and tested for the interaction with eiF4H. 
Electrophoretic mobility shift assay (EMSA) or gel shift assay is a 
common affinity electrophoresis technique used to study protein-DNA or protein-
RNA interactions (108). This assay can determine if a protein or mixture of proteins 
is capable of binding to a given DNA or RNA sequence, and can even indicate if more 
than one protein is involved in the binding complex. 
60 
A 
c 
Full Length eiF4A(1-406) '----------' 
eiF4A_NTD (1-244) 
eiF4A_CTD (237-406) 
Full-length eiF4A 
e1F4A _NTO Ladder 
.... _ 
'J<o. t -
... __ 
·· -- -~ ·
-. -.. -
eiF4A 
_CTO 
8 
0 
eiF4A + + 
eiF4A NTD + + 
eJF4A_CTD + + 
ei4H + + + + 
Figure 25 - eiF4H binds to eiF4A-NTD but not eiF4A-CTD (A) Construct of 
plasmids of eiF4A-NTD and eiF4A-CTD (B) Crystal structure of eiF4A-NTD (green) and 
eiF4A-CTD(blue) based on the full length eiF4A(PDB ID code 2ZU6) (C)SDS-PAGE analysis 
gel using Bio-Rad Experion Pro260 protein chip assay. The molecular weight of full length 
eiF4A is -48KDa. The molecular weight of eiF4A-NTD and eiF4A-CTD are -26KDa and 
-23KDa respectively. (D) Mapping the eiF4H binding sites on eiF4A. Gel shift analysis 
indicating binding of the eiF4H onto full length eiF4A (lane 5) and eiF4A-NTD (lane 6) but 
not eiF4A-CTD (lane 7). Therefore N-terminal domain of eiF4A is sufficient for binding 
eiF4H. 
As shown in Figure 25D, the gel shift analysis demonstrates that in the 
presence of RNA hairpin eiF4H binds to theN-terminal domain of e1F4A but not to 
the C-terminal domain. Figure 25D also illustrates that e1F4A alone cannot binds to 
RNA hairpin. And the interesting observation here is that eiF4A-NTD itself shows 
some weak binding activity to RNA hairpin. Lane 4 and lane 5 clearly show that 
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there is a cooperative binding effect between eiF4A and eiF4H to RNA hairpin. We 
could detect no stable association of eiF4A-CTD and eiF4H. Therefore it is possible 
that during RNA unwinding the N-terminal domain of eiF4A binds tightly to eiF4H 
which binds to the loop structure of RNA hairpin, while C-terminal domain may 
undergo free rotation. 
3.2.4 Both domains are necessary for the repetitive unwinding 
To further test whether the N-terminal domain of eiF4A is sufficient for 
unwinding RNA duplex, we compared the helicase activities of full length eiF4A, 
eiF4A-NTD and eiF4A-CTD. Interestingly, eiF4A-NTD but not eiF4A-CTD shows 
similar bulk unwinding activity as full length eiF4A in the presence of ATP (Figure 
26). 
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eiF4A CTD + + + 
ATP + + + + + 
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Figure 26- Helicase activities of eiF4A, eiF4A-NTD and eiF4A-CTD. As 
shown in lane 2 and lane 4, without ATP neither eiF4A nor eiF4A-NTD can 
unwind 15 bp RNA/DNA duplex. eiF4A-NTD shows similar unwinding activity 
as full length eiF4A (lane 3 and lane 5) in the presence of ATP. eiF4A-CTD 
does not show unwinding activity and the mixture of eiF4A-NTD and CTD 
shows similar activity as eiF4A-NTD alone. 
To determine whether eiF4A-NTD or the mixture of eiF4A-NTD and CTD can 
repetitively unwind the RNA hairpin, we conducted smFRET experiments with Cy3-
CyS labeled RNA hairpin as described in Chapter 2. Figure 27 illustrates that neither 
eiF4A-NTD nor the mixture of NTD and CTD can repetitively unwind the RNA 
hairpin substrate. Therefore both NTD and CTD domains are necessary for the 
repetitive unwinding of RNA hairpin substrate and they have to be connected 
through the linker. The hypothesis is that the interaction of the two domains of 
eiF4A plays an essential role in the repetitive unwinding of RNA hairpin. 
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Figure 27 - No repetitive unwinding activity observed for eiF4A-NTD and 
the mixture of eiF4A-NTD and CTD. (A) A representative single-molecule time 
trace of substrate in the presence of eiF4A-NTD, eiF4H, and ATP. The substrate is 
an RNA/DNA hairpin with a 12-nucleotide long loop, labeled with a FRET pair (see 
Figure 24A). N > 1000 traces. (C) No repetitive FRET fluctuation is detected in the 
presence of 111M eiF4A-NTD/CTD mixture, eiF4H and ATP. N > 1000 traces. 
3.2.5 eiF4A adopts a closed conformation in the presence of AMPPNP 
To probe the interaction of the two domains of eiF4A, we labeled eiF4A and 
used single-molecule FRET (smFRET) to probe the distance change between the 
donor and acceptor. Freely diffusion smFRET measurement can provide invaluable 
information about the distributions of molecular properties of interest without 
disturbing by the surface effects. Because a large number of photon bursts events 
can be collected in a relatively short time, statistical analysis of these data is 
possible and histograms can be constructed. 
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Figure 28 - Single-molecule FRET using confocal microscopy. (A) Schematic of 
confocal single molecule detection of eiF4A in solution. A detailed description of the 
setup is given in section 3.4.3. Laser light is focused into the confocal volume. The 
fluorescence emission of freely diffused molecule is collected by the same objective and 
split into donor and acceptor spectral regions through a high numerical aperture 
objective. (B) The passage of individual eiF4A through the confocal volume due to free 
diffusion generates bursts of fluorescence. Time trace of donor (green) and acceptor 
(red) fluorescence from donor/acceptor-labeled eiF4A. (C) Histogram of apparent FRET 
efficiencies, calculated burst-wise for individual molecules from donor and acceptor 
fluorescence intensities. (D) Dwell time histogram of burst events. 
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Figure 29 - Histogram of FRET of eiF4A with different labeling positions (A) 
eiF4A labeled at different domain (B) FRET histogram of 4A-14 (C) N-terminal domain of 
4A labeled with both donor and acceptor (D) FRET histogram of 4A-12 (E) eiF4A with 
both donor and acceptor labeled inC-terminal domain (F) FRET histogram of 4A-45. 
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Figure 28 shows the diagram of freely diffusion confocal microscopy. Single 
molecules passing the confocal volume due to free diffusion will cause bursts of 
fluorescence. For each burst a proximity ratio is calculated and data binned for 
histogram analysis. The FRET is calculated as 
The leakage of donor emission into the acceptor channel W-10%) is 
calibrated using mutant eiF4A labeled with single Cy3 dye. The FRET efficiency 
histogram of freely diffused eiF4A labeled at different domain shows a peak at -0.3 
(Figure 29B). The FRET efficiency histogram of eiF4A labeled inN-terminal domain 
or (-terminal domain shows a peak at -0.9. (Figure 29D and 29F) Therefore eiF4A 
is a distended molecule in solution and the two domains have compact form, which 
is consistent with the crystal structure of both yeast and human eiF4A. 
When we added eiF4H, RNA hairpin and AMPPNP to eiF4A labeled at 
different domain, we observed a clearly FRET peak shift from 0.3 to 0.8, indicating 
eiF4A adopts a closed conformation upon binding to RNA (Figure 30A). For eiF4A 
with both donor and acceptor labeled in C-terminal domain, we only observed a 
slight change of FRET from 0.9 to 0.8 (Figure 30B). 
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Figure 30 - eiF4A adopts a 'closed' conformation in presence of AMPPNP, 
eiF4H and RNA hairpin (A) FRET histogram for eFI4A labeled in different domains (see 
Figure 29A) (B) FRET histogram for eFI4A labeled in the CTD domain (see Figure 29E) 
One of the limitations of freely diffusion smFRET measurement is that the 
bursts are short (Figure 28D) and provide less information on slower 
conformational dynamics. The dwell time histogram of burst events is shown in 
Figure 28D. The observation time of the most of the events is less than 2ms. In order 
to capture the slow dynamics of the conformation change of e1F4A ('ru =0.7sec in 
Figure 12C) during RNA unwinding, we have to increase the observation time and 
one solution is to immobilize double-labeled eiF4A on surface. 
3.2.6 Surface immobilization of eiF4A using lipid vesicles 
To capture the slow dynamics of the conformation change of eiF4A and 
minimize hindrance from surface immobilization, we used DMPC lipid vesicles with 
200 nm diameter to encapsulate and immobilize the eiF4A/4H complex and RNA 
hairpin (Figure 31A). The DMPC vesicle is readily porous at the lipid transition 
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temperature. The double-labeled eiF4A was encapsulated with eiF4H and RNA 
hairpin and single-molecule FRET values from individual surface-immobilized eiF4A 
were measured. Based on the measurement with Dynamic Light Scattering (DLS), 
the measured diameter of the vesicle is pretty uniform at a given range of 
temperature. 
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Figure 31 - Schematic of vesicle encapsulation containing double-labeled 
eiF4A. The structure of eiF4A (PDB ID code 2ZU6) (111) shows a dumbbell structure of 
two compact domains connected by an extended linker, with Cy3 and CyS attached to 
the NTD and CTD of eiF4A respectively (not to scale). Using dimyristoyl 
phosphatidylcholine (DMPC) at room temperature, vesicles selectively permeable to 
small molecules can be used to trap eiF4A, eiF4H and RNA hairpin. A fraction of 
biotinylated lipid allows specific tethering of the vesicles to the biotin-streptavidin 
surface. (B) The diameter of the vesicles is measured with Brookhaven 90 plus Nano-
particle Sizer, and the measured diameter is -170-nm at room temperature (23°C). The 
diameter of the vesicle is pretty uniform at a large range of temperature (20°( -32 °C). 
To test whether the encapsulation and surface immobilization interfere with 
the helicase activity, we first performed single-molecule experiments by measuring 
the conformational change of eiF4A in the presence nonhydrolyzable ATP analog, 
69 
AMPPNP. As shown in Figure 32, in the presence of AMPPNP, histogram of inter-
domain labeled eiF4A (Figure 29A) shows FRET peak shifts from ~0.5 to ~0.8, which is 
consistent with previous freely diffusion smFRET measurements (Figure 30A). The 
conclusion is the DMPC vesicle encapsulation does not interfere with the 
conformational change of eiF4A. 
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Figure 32 - AMPPNP induces a 'closed' conformation of eiF4A. Donor and 
acceptor are labeled in different domains of eiF4A (see Figure 29A) (A) 
Representative single-molecule FRET trace (B) FRET histogram shows low FRET 
peak -0.5 (C) Representative single-molecule FRET trace of double labeled eiF4A 
(see Figure 29A) with RNA hairpin, eiF4H and AMPPNP (D) FRET histogram shows 
FRET eak shifts to-0.8 in the resence of AMPPNP. 
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3.2. 7 'Open-closed' conformational changes during RNA unwinding 
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Figure 33 - sm-FRET measurements of double labled eiF4A in the presence of 
RNA haipin, eiF4H and ATP. (A) A representative single-molecule time trace of double 
labeled eiF4A (schematic illustration in Figure 29A). The eiF4A is co-encapsulated with 
eiF4H and RNA haipin and then immobilized to the coverslip surface through biotin-
streptavidin interaction. ATP are introduced at a concentration of lmM in imaging 
buffer. Donor (In) and acceptor (lA) intensities (green and red, respectively) are 
measured and the corresponding FRET trace is calculated by lA /( lA + In )(blue). (B) 
Histogram of FRET levels showing two peaks at 0.8 and 0.4 respectively. (C) Dwell 
times of the low- and high-FRET states are used to construct the time histograms of the 
'open time' and 'closed time' intervals (blue and green, respectively) of the 
conofrmation. Single exponential models are used to fit the data, yielding the 
characteristic timescales Topen (0.79sec) and Tciosed (1.28 sec). 
Figure 33 summarizes the single-molecule FRET results of eiF4A in the 
presence of eiF4H, RNA hairpin and ATP. Two FRET levels are defined here: one 
"high FRET" (or "closed") conformation and one "low FRET" (or "open") 
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conformation. We observed the transitioning between an "open" and a "closed" 
conformation of the inter-domain labeled eiF4A using the energy from ATP 
hydrolysis. Since the transitions in FRET value from 0.8 to 0.4 reflect roughly a 2nm 
change in donor-acceptor distance, and given that the FRET transitions are ATP-
dependent, the results are consistent with previous results that eiF4A repetitive 
unwinds RNA hairpin. 
Each oscillation of the FRET trace between the high and low level represents 
a single 'open' and 'closed' cycle of eiF4A. A Hidden-Markov Model (HMM) analysis 
was used to extract the dynamics of this conformational change, characterized by 
'closed time' (dwell time at high FRET level) and 'open time' (dwell time at low 
FRET level). Statistical analysis of hundreds of these transitions revealed 
exponential distributions of the dwell times for each state, where the characteristic 
'open time' is Topen=0.79±0.05 sec and the characteristic 'closed time' is Tciosed 
=1.28±0.05 sec (Figure 33). And most importantly we can successfully correlate 
Topen to Tu, and Tciosed to Tw (Figure 12C). 
Taken together, these findings suggest that upon binding of an RNA hairpin 
and ATP, which is mediated by eiF4H, eiF4A adopts a 'closed' conformation; after 
ATP hydrolysis, eiF4A returns to the open conformation, the RNA duplex is 
completely unwound, and the RNA is released, quickly re-annealing to reform the 
hairpin. The extended and flexible linker should be the structural basis for these 
rapid conformational changes. 
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3.2.8 Inter-domain interaction is responsible for the helicase activity 
To rule out the possibility of the observed conformational change is due to 
the intra-domain interaction, we further run single-molecule experiment with 
double-labeled eiF4A which has both donor and acceptor in the same domain 
(Figure 29E). Figure 34 further illustrates that during the repetitive 'open' and 
'closed' conformation change of eiF4A, the FRET change in CTD is subtle, i.e. the two 
RecA domains are very rigid. This experiment confirms that the inter-domain 
interaction is responsible for the helicase activity of eiF4A. 
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Figure 34 - smFRET experiments with intra-domain labeled eiF4A (A) 
Representative single-molecule FRET trace of elF4A with donor and acceptor labeled in 
CTD domain (Fig. 3.6E) in the presence of eiF4H, RNA hairpin and ATP. No trace shows 
oscillating of FRET. (B) FRET histogram shows high FRET peak at ~0.8. 
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3.3 Conclusions and discussion 
In summary, we propose the following mechanism for the repetitive unwinding 
of RNA hairpins by the eiF4AfeiF4H complex. Initially eiF4A adopts an open 
conformation in solution. Figure 29B illustrates that eiF4A alone remains mainly in 
the low FRET state if the donor and acceptor are at different domains. For the el4A 
which is labeled in the same domain (NTD or CTD), only high FRET is 
observed. Upon binding to RNA and ATP, eiF4A adopts a closed conformation as 
shown in Figure 35. After ATP hydrolysis, eiF4A returns to the open conformation 
and the RNA duplex is completely unwound. Then the eiF4A releases one strand of 
the RNA and the hairpin is quickly reformed. In the presence of nonhydrolyzable 
analogue of ATP, AMPPNP, eiF4A cannot efficiently unwind the 15 bp RNA/DNA 
duplex because it maintains a closed conformation. 
We find that during the repetitive unwinding of RNA hairpin, eiF4H binds to 
the loop structure of RNA hairpin and the N-terminal domain of eiF4A. The CTD is 
connected to NTD through the flexible and extended linker and CTD itself shows 
very low binding affinity to eiF4H (Figure 35B). Although eiF4A-NTD itself shows 
similar bulk helicase activity as that of the full length elF 4A, both NTD and CTD are 
necessary for the repetitive unwinding of RNA hairpin structure. 
We have characterized the repetitive unwinding of RNA hairpin by 
eiF4AfeiF4H complex in Chapter 2. By monitoring both the inter-domain and the 
intra-domain distance change, our results extend previous studies implicating the 
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conformation change and eiF4A/eiF4H interaction are essential for eiF4A's 
repetitive unwinding activity. 
A recent NMR study has shown that eiF4G enhances the helicase activity of 
elF 4A by acting as a soft clamp to stabilize the closed orientation of the two helicase 
domains of eiF4A, thus aiding the formation of ATPase and RNA-binding sites in the 
helicase (135). The study also shows that the C-terminal domain (CTD) of e1F4A is 
sufficient for binding the middle domain of eiF4G (e1F4G-m, amino acids 745-1003). 
However, the interaction of eiF4G-m with full-length eiF4A is stronger than that 
with eiF4A-CTD alone (135). Therefore the two domains of eiF4A may show 
different affinity to different cofactors of eiF4A e.g. eiF4H and eiF4G, and these 
cofactors may use different mechanisms to stimulate the helicase activity of eiF4A. 
The similar closed conformations of YxiN, Mss116, Vasa, and eiF4A-III (65-
67, 96) suggest a conserved mechanism of ATP energy conversion among DEAD box 
helicases. Our experiments open avenues to probe the conformational change of 
DEAD box helicase in the catalytic cycle in real time and to correlate its kinetics with 
unwinding activity. 
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Figure 35 - Mechanism of how eiF4A/ eiF4H complex repetitively unwinds RNA 
hairpin. (A) In solution eiF4A adopts an open conformation. When eiF4A binds to an RNA 
hairpin and ATP, which is mediated by eiF4H, it adopts a closed conformation. After ATP 
hydrolysis, eiF4A returns to the open conformation, the RNA duplex is completely 
unwound, and then RNA is released, quickly re-annealing to reform the hairpin. (B) During 
unwinding, eiF4H binds to the loop structure of RNA hairpin and the N-terminal domain 
(NTD) of eiF4A. C-terminal domain (CTD) is connected toN-terminal domain through the 
flexible and extended linker. 
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3.4 Materials and Methods 
3.4.1 Site-directed mutagenesis of mutant eiF4A 
Proteins were expressed and purified as described in Chapter 2. Site-directed 
mutagenesis was performed according to the Quikchange protocol (Agilent, Santa 
Clara, CA). eiF4A-NTD (aa 1-244) was constructed by introducing a stop codon after 
the codon for aa 244. For eiF4A-CTD (aa 237-406), an Ndel restriction site 
(CATATG) was introduced after the coding region for aa 1-234, and the region 
between the two Ndel restriction sites was deleted by cleavage and subsequent 
ligation. Correct sequences were confirmed for all constructs. 
3.4.2 Double labeling and purification of mutant eiF4A 
Proteins were labeled by incubation with a mixture of Cy3- maleimide 
(donor) and CyS- maleimide or Atto647N-maleimide (acceptor), respectively, 
overnight at 4°C. Protein concentrations were 2 mgjml. Dyes were used at 
concentrations of at least 5 fold molar excess with respect to the protein. The 
reducing agent tris(2-carboxyethyl)phosphine (TCEP) was added to the reaction at 
2 mM to reduce any disulfides in the protein sample. Free dyes were removed from 
the labeled sample using a Q sepharose column (GE Healthcare, Piscataway, NJ). 
After loading the proteins on the column, the resin was washed with 100ml A100 
buffer to get rid of the free dyes. The rest of the elution procedure was the same as 
section 2.4.2. 
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3.4.3 FRET measurements of freely diffusing molecules 
Freely diffusion smFRET measurements were carried out using a home-built 
laser confocal microscope system. Excitation was achieved by focusing a 532 nm 
line laser (New Focus, Santa Clara, CA) into the sample solution using a 60X 1.2 NA 
UPlanApo water immersion objective (Olympus, Japan). The emission part 
comprised a long-pass filter (Chroma HQ560LP) to remove the scattered light. The 
fluorescence emission was collected using the same objective, separated from the 
excitation light using a dichroic mirror (Chroma, Rockingham, VT), spatially filtered 
using a 100-flm pinhole. The emission was then spectrally split onto two APDs, one 
for 550-620 nm and the other for 650-710 nm. Photon counts were recorded using a 
counting card (PCI 6602; National Instruments, Austin, TX) interfaced with a custom 
Lab VIEW program. The sampling rate is 10KHz (100us). 
FRET efficiency histograms were generated by using a two-channel data 
collection mode to simultaneously record donor and acceptor intensities as a 
function of time, with a binning time of 500 flS. The concentration of double-labeled 
protein used was -20 pM, ensuring that all of the detected signals were from single 
molecules. The leakage of donor emission into the acceptor channel (~-10%) was 
determined using mutant eiF4A (only one cysteine at position 66) labeled with 
single Cy3 dye, and then it is used to correct the signals before FRET 
analysis. Histograms were fitted with Gaussian functions, carrying out nonlinear 
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least squares analysis for the fitting using Matlab (Mathworks, Natick, MA) or Igor 
Pro (WaveMetrics, Lake Oswego, OR). 
3.4.4 Vesicle encapsulation of RNA hairpin, eiF4A and eiF4H 
Encapsulation in lipid vesicles was performed as described in (127, 129). 
Lipid films were prepared by mixing 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(Cap Biotinyl) with dimyristoyl phosphatidylcholine 
(DMPC) (Avanti Polar Lipids, Inc.) dissolved in chloroform (1:100 molar ratio) and 
gently drying in vacuum. The lipids were hydrated with buffer containing 20 mM 
Tris-HCl (pH 7.5) and 50 mM sodium chloride. RNA hairpin was incubated with 
eiF4A and eiF4H at room temperature for 5 min in the protein buffer, which 
contains 50 mM Tris-HCl (pH 7.5) 50 mM sodium chloride and 2 mM magnesium 
chloride. These solutions were mixed 1:1 in volume so that the mixture has 
12.5 mg/mllipids and 400 nM RNA hairpin. It was manually extruded through track-
etched membrane with 200 nm holes (Whatman) more than 20 times to induce 
encapsulation. 
3.4.5 smFRET measurements of immobilized molecules 
Total internal reflection fluorescence (TIRF) microscopy as described 
previously in Chapter 2 is used for the single-molecule imaging of double labeled 
eiF4A. We immobilized 100pM DMPC lipid vesicles which encapsulate RNA hairpin, 
eiF4H and double-labeled eiF4A, directly on biotinylated BSA-streptavidin coated 
quartz cover slip. FRET values were calculated as IA/(IA+Io), where lA and Io are the 
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fluorescence intensities of the acceptor and donor channels, respectively, following 
background correction. 
3.4.6 Electrophoretic mobility shift assays 
Electrophoretic mobility shift assays (EMSA) reactions were performed in a 
binding buffer (20mM Tris-HCl, pH 7.5, 50mM KCl, 2.5mM MgC12, and lmM DTT). 
Reactions containing the indicated proteins and Cy5-labeled RNA were performed 
at room temperature for 30 min. The RNA/DNA hairpin substrate included a 12-nt 
long loop and a 12-bp stem region. The single-stranded overhang region consisted 
of 23 nt. A Cy5 fluorophore was attached to the 5' end of RNA. Samples were loaded 
onto 7.5% non-denaturing polyacrylamide gel and following electrophoresis, gels 
were scanned for Cy5 emission using a Pharos FX Scanner (BioRad, Hercules, CA). 
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Chapter 4: Regulation of eiF4A function 
4.1 Introduction 
Targeted cancer therapies are drugs designed to interfere with specific 
molecules necessary for tumor growth and progression (10, 14, 136). Traditional 
cytotoxic chemotherapies usually kill rapidly dividing cells in the body by 
interfering with cell division. A primary goal of targeted therapies is to fight cancer 
cells with more precision and potentially fewer side effects. A major endeavor in 
cancer chemotherapy is to develop agents that specifically target a biomolecule of 
interest. There are two main classes of targeting agents: antibodies and small 
molecules (137). Therapeutic monoclonal antibodies target specific antigens found 
on the cell surface, such as transmembrane receptors or extracellular growth 
factors. Among antibodies, DNA, RNA but also peptide aptamers are relatively 
recent agents. The development of the systematic evolution of ligands by 
exponential enrichment (SELEX) process (138, 139), made possible the isolation of 
oligonucleotide sequences with the capacity to recognize virtually any class of target 
molecules with high affinity and specificity. These oligonucleotide sequences, 
referred to as "aptamers", are beginning to emerge as a class of molecules that rival 
antibodies in both therapeutic and diagnostic applications. 
Unlike antibodies, small-molecule agents can translocate through plasma 
membranes and interact with the cytoplasmic domain of cell-surface receptors and 
intracellular signaling molecules (137). Small molecules are usually designed to 
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interfere with the enzymatic activity of the target protein. Currently, various small-
molecule inhibitors have been developed to target cancer-cell proliferation and 
survival by inhibiting PI3K/Akt/mTOR pathway (140) or heat shock protein 90 
(HSP90) (141). 
Of the ~150,800 recorded clinical trials (http:/ /clinicaltrials.gov f, last 
access: August 30th, 2013), ~7,080 are involving targeted therapies, with ~6,800 in 
the field of oncology. Among these, there are only 22 studies assessing aptamers and 
329 studies concerning small molecules. More effort will be required to realize the 
full potential of small molecules and aptamers in this regard. 
4.1.1 Small molecule hippuristanol 
Hippuristanol is a small molecule found in the coral Isis hippuris. The natural 
product hippuristanol targets eukaryotic translation initiation factor eiF4A (21, 
142). The molecular weight of Hippuristanol is 463Da. It was discovered as a 
translation inhibitor using a high-throughput screen designed to identify 
compounds that target specifically cap-dependent translation (21). Hippuristanol 
can suppress proliferation of HTLV-1-infected T-celllines and adult T-cellleukemia 
(ATL) cells in mice, but not normal peripheral blood mononuclear cells (143) 
(Figure 36). Inhibition of eiF4A selectively and simultaneously modulates the 
synthesis of proteins involved in Alzheimer's disease (AD): reducing A-beta and tau 
synthesis, while increasing proteins predicted to be neuroprotective (144) . These 
effects could represent a novel approach to AD intervention. 
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Figure 36 - Characterization of eiF4A activity regulated by hippuristanol A) 
Chemical structure of hippuristanol. (B) Inhibition of growth of HUT-102 cells in SCID 
mice. Growth of the tumors after inoculation of HUT-102 cells subcutaneously. ( C ) 
Transferase dUTP nick end labeling (TUNEL) assays show apoptotic cells in tumors from 
mice treated with or without hippuristanol. Note the presence of few apoptotic cells in 
tumors from the untreated mice, compared with the abundant apoptotic cells in tumors 
from the hippuristanol-treated mice (bottom). Figure adapted from (143) 
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Figure 37 - Effect of hippuristanol on ATP hydrolysis, ATP-binding and RNA-
binding activities of eiF4A. (A) Hippuristanol inhibits eiF4Af RNA-dependent ATPase 
activity. (B) Hippuristanol does not inhibit ATP cross-linking to eiF4Af or eiF4Ac. (21) 
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Hippuristanol inhibits eiF4Af (eiF4A exists a free form) RNA-dependent 
ATPase activity, but does not inhibit ATP cross-linking to eiF4Af or eiF4Ac (eiF4A as 
a subunit of eiF4F) (Figure 37). It is shown this coral-derived natural product binds 
to amino acids adjacent to, and overlapping with, two conserved motifs present in 
the carboxy-terminal domain of eiF4A (Figure 38). 
Figure 38 - Hippuristanol binds to eiF4A-CTD. Location of the hippuristanol-
binding site in a model for eiF4A which forms a complex with RNA and AMPPNP. The 
hippuristanol-binding site on the eiF4A-CTD is directly adjacent to the ATP-binding site 
in the CTD. (142) 
4.1.2 RNA aptamer 
Aptamers are artificial molecules isolated from large combinatorial nucleic 
acid libraries by their high affinity to a target molecule. There are however, several 
unique features of aptamers that are of additional benefit. Aptamers are not 
potentially immunogenic and mostly not toxic to cells. They are robust against both 
reducing conditions and heat denaturation. Finally, they are chemically 
synthesizable and their antidote molecules can be easily designed. Thus, the 
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application of aptamers in molecular biology and medical science has been 
extensively explored. 
Pegaptanib (Macugen) (145, 146), the first aptamer-based therapy targeting 
VEGF (vascular endothelial growth factor) to block abnormal blood vessels to grow 
and leak, was approved by the United States Food and Drug Administration (FDA) as 
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Figure 39 - Overview of the SELEX process. The initial DNA pool, flanked by the 
fixed primer-binding sites and a T7 promoter, is transcribed into RNA (a). The resulting 
RNA library is subjected to counter selection, in order to remove molecules that 
unspecifically bind to the membrane (b). After the protein-binding reaction with the 
counter-selected pool (c), sequences binding to the protein of interest are selected via 
filter binding (d). Protein-bound RNAs are retained on the membrane, whereas non-
binding RNAs are eluted. Selected RNAs are recovered via protein denaturation and PCl 
extraction (e), reverse transcribed into DNA (f) and amplified via PCR (g) . The resulting 
pool is either subjected to another round of SELEX, or cloned and sequenced. Figure 
adapted from (147) . 
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the therapy for the treatment of age-related macular degeneration (AMD) in 
December 2004. 
An in vitro RNA selection method termed SELEX (Figure 39) (138, 139, 147) 
was used to identify RNA molecules that are able to bind eiF4A. Of those selected in 
(148), aptamer 21 stood out for its ability to alter eiF4A activity by inhibiting its 
ATPase activity and thus suppressing translation initiation in vitro. Aptamer 21 is an 
87 nt, highly structured RNA molecule that contains a core 58 nt region .16.123 
responsible for its interaction with eiF4A (148). Due to the ease and low cost of 
their manufacture, aptamers offer a financially viable way of targeting specific 
proteins both for research and therapeutic intervention. 
4.2 Inhibition effect of eiF4A by small molecule Hippuristanol 
4.2.1 eiF4A helicase activity is inhibited by hippuristanol 
First we characterized the effect of small molecule hippuristanol on the 
helicase activity of eiF4A. Titration assay were carried out in the presence of 2uM 
eiF4A and 2mM ATP and 2mM MgCl2. The assays were performed in 20 111 
of helicase activity buffer. When the concentration of hippuristanol is SX of elF 4A, it 
can completely inhibit the activity of eiF4A (Figure 40). This result is consistent 
with previous report that hippuristanol specifically inhibits the helicase activity of 
eiF4A (21, 142). 
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Figure 40 - Characterization of eiF4A helicase activity inhibition by 
hippuristanol. lOuM hippuristanol can completely inhibit the helicase activity of eiF4A. 
4.2.2 Hippuristanol does not inhibit the binding of eiF4A/eiF4H to RNA 
hairpin 
eiF4A + + 
eiF4A NTD + + 
eiF4A CTD + + 
eiF4H + + + + + + + 
Hippurlstanol + + + 
Figure 41 - EMSA reactions of RNA hairpin. Hippuristanol does not inhibit the 
binding activity of eiF4A/eiF4H complex to RNA hairpin. eiF4H itself can bind to RNA 
hairpin (Lane 1) and eiF4A/eiF4H shows cooperative binding effect to RNA hairpin 
(Lane 2). Hippuristanol does not or slightly inhibit the binding of eiF4afeiF4H complex 
to RNA hairpin (Lane 3). eiF4H binds to eiF4A-NTD and hippuristanol does not interfere 
with the binding between eiF4A-NTD and eiF4H. (Lane 4 and 5) Lane 6 and lane 7 
show that hippuristanol does not inhibit the binding between eiF4H to RNA hairpin. The 
concentration of hi uristanol is lOuM. 
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To understand how hippuristanol inhibits the helicase activity of eiF4A, we 
studied whether hippuristanol interfere with the binding of eiF4A to eiF4H or RNA 
hairpin. EMSA reactions of RNA hairpin show that hippuristanol does not or slightly 
inhibit the binding activity of eiF4A/eiF4H complex to RNA hairpin (Figure 41). 
Lane 4 and 5 in Figure 41 show that hippuristanol does not interfere with the 
binding between eiF4A-NTD/eiF4H and RNA hairpin, which is consistent with that 
the binding site ofhippuristanol is in eiF4A-CTD. 
4.2.3 Single-molecule study of inhibition effect ofhippuristanol 
To investigate whether there is an intermediate state of unwinding in the 
presence of hippuristanol and how hippuristanol change the unwinding kinetics of 
eiF4A, we first performed sm FRET study with double labeled RNA hairpin (Figure 
42A). In the presence of 10uM hippuristanol, the RNA hairpin always shows high 
FRET and no repetitive unwinding trace was observed (Figure 42C). These results 
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Figure 42 - Hippuristanol completely suppresses the repetitive unwinding of RNA 
hairpin by wild type eiF4A. (A) RNA hairpin labeled with donor and acceptor. (B) 
Representative repetitive unwinding trace before adding hippuristanol. N > 500 traces. 
(C) Representative repetitive unwinding trace after adding 10uM hippuristanol. N > 
500 traces. 
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are in good agreement with the inhibition effect of hippuristanol on helicase activity 
of eiF4A. 
To further illuminate the mechanism how hippuristanol inhibits the helicase 
activity of eiF4A, we probed how the conformation of eiF4A is changed when it 
binds to hippuristanol. Figure 43 illustrates that in the presence of lOuM 
hippuristanol less than 1% of the traces show conformational change. The 
eiF4AjeiF4H complex can still bind to RNA hairpin; however eiF4A cannot undergo 
open-closed conformation change because the ATP hydrolysis is suppressed by 
hippuristanol. Therefore, we concluded that hippuristanol binds to eiF4A and blocks 
the conformational change of eiF4A. This is supported by the observation that 
hippuristanol inhibits the RNA-dependent ATPase activity of eiF4A, but does not 
inhibitATP cross-linking to eiF4A (Figure 37). 
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Figure 43 - Single-molecule FRET studies show that hippuristanol blocks the 
conformational change of eiF4A. (A) eiF4A labeled with donor and acceptor in different 
domains (B) Representative smFRET trace of labeled eiF4A in presence of eiF4H, RNA 
hairpin and ATP. N > 500 traces. (C)Representative trace with 10uM hippuristanol. Less 
than 1% trace shows conformational chan e. N > 500 traces. 
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4.3 Both eiF4A and eiF4H bind to RNA aptamer 
4.3.1 Helicase activity of eiF4A is inhibited in the presence of RNA aptamer 
To investigate the effect of RNA aptamer on the helicase activity of eiF4A we 
first conduct bulk helicase assay with DNA/RNA duplex. Figure 44A shows the 
secondary structure of the RNA aptamer. The sequence of RNA aptamer is 5'- GGG 
UAG ACG CUC AAG GGG ACC GCG CCC CAC AUG UGA GUG AGG CCG AAA CGU AGA 
UUC GAC AGG AGG CUC ACA-3'. The sequence of the aptamer is based on the core 58 
nt region Ll6Ll23 from (148). The molecular weight of RNA aptamer 1s -22 KDa. 
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Figure 44 - Characterization of eiF4A activity inhibited by RNA aptamer (A) RNA 
aptamer shows rich secondary structure. The length of RNA aptamer is 72nt and the 
molecular weight is 22 KDa. (B) Inhibition effect of RNA aptamer on eiF4A. RNA aptamer 
can completely inhibit the helicase activity of eiF4A. The concentration of RNA/DNA duplex 
is 10nM and the concentration of eiF4A is 2uM. 
As shown in Figure 44 the helicase activity of eiF4A is strongly inhibited 
when the concentration of RNA aptamer is Sx that of eiF4A. To rule out the 
possibility that the inhibition effect of eiF4A is because 4A can bind to ssRNA 
without specific structure. We performed control experiments with unstructured 
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67nt ssRNA (A)zs(C)4z which has similar length as RNA aptamer. As shown in Figure 
45, unstructured RNA does not interfere with the helicase activity at all. Therefore 
we conclude that the inhibition effect of eiF4A helicase activity by RNA aptamer is 
sequence specific. The binding affinity between eiF4A and RNA aptamer is much 
higher than that of DNA/RNA duplex or unstructured single strand RNA (A) 25 (C) 42. 
This is consistent with that eiF4A does not contain any RNA-recognition motifs and 
do not exhibit strong binding to unstructured RNA. 
eiF4A + + + + + + + + + 
ATP + + + + + + + + 
67nt ssRNA(uM) 0.01 0.05 0.1 0.5 1 5 10 
Figure 45 - Unstructured single-strand RNA does not interfere with the helicase 
activity of eiF4A. The sequence of the RNA is (A)25(C)42. The concentration of 
RNA/DNA duplex is lOnM and the concentration of eiF4A is 2uM. The concentration of 
ATPis 2mM. 
4.3.2 RNA aptamer binds directly to eiF4A and eiF4H 
Next we investigate whether the RNA aptamer interferes with the interaction 
between eiF4H and RNA hairpin. Figure 46 illustrates that although this RNA 
aptamer is screened based on the high affinity for eiF4A by in vitro RNA selection-
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amplification, it can also strongly bind to eiF4H, because the loop structures of RNA 
aptamer are larger than 6nt (see Figure 44A). 
eiF4A + + + 
eiF4A_NTD + + 
eiF4A_CTD + + 
eiF4H + + + + + + + + 
RNA aptamer + + + + 
Figure 46 - eiF4A/eiF4H binding activity to RNA hairpin is regulated by RNA 
aptamer. The concentration of RNA hairpin is 20nM. The concentration of 4A/4H is 2uM. 
The concentration of RNA aptamer is SuM. The binding affinity between eiF4A alone and 
RNA hairpin (12nt loop and 12bp duplex) is very weak (Lane 1). eiF4H can bind to the 
loop structure of RNA hairpin(Lane 2). RNA aptamer directly competes with RNA hairpin 
for the binding to eiF4H. 
To test the hypothesis that RNA aptamer can strongly bind to both eiF4A and 
eiF4H, we further examined the direct binding of RNA aptamer to eiF4A and eiF4H 
respectively. The gel shift assays in Figure 4 7 illustrate that both full length elF 4A 
and eiF4A-NTD can bind to RNA aptamer, but eiF4A-CTD cannot bind to RNA 
aptamer. Mixing of both eiF4A-NTD and eiF4A-CTD shows almost the same binding 
effect as eiF4A-NTD. Our results are not consistent with previous study in (148), 
where it was shown that neither eiF4A-NTD (1-235) nor eiF4A-CTD(216-406) 
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exhibited high affinity for the RNA aptamer; mixing of both domains had only a 
slight effect. Comparing with the binding of eiF4A to RNA hairpin in Figure 25D, we 
conclude that the selected RNA aptamer interacts cooperatively with both domains 
of eiF4A and the high binding affinity is sequence or structure specific. 
More importantly we also observed that the binding affinity between RNA 
aptamer and eiF4H is much stronger than that between aptamer and eiF4A (lane 2 
and lane 5 in Figure 4 7 A). This is consistent with our result in Chapter 2 (Figure 
25). Then to further quantify how many eiF4Hs bind to RNA aptamer, we did 
titration experiments to study the binding of RNA aptamer to eiF4H. The 
concentration of RNA aptamer is 200nM and the concentration of eiF4H increased 
A B 
eiF4A + + 
eiF4A_NTD 
eiF4H(uM) e1F4A_CTD 
ei4H 
Figure 47- Binding activity of RNA aptamer to eiF4A and eiF4H. The concentration 
of RNA aptamer is 200nM. (A) Both full length eiF4A and eiF4A-NTD can bind to RNA 
aptamer (lane2 and lane 3), however eiF4A-CTD cannot bind to RNA aptamer (lane 4). The 
concentration of eiF4A or 4H is 2uM. The binding affinity between RNA aptamer and eiF4H 
is much stronger than RNA aptamer and eiF4A (Lane 5). (B) RNA aptamer directly binds to 
eiF4H. The concentration of eiF4H increased from 0.1 uM to 2uM (from lane 2 to lane 8). 
Onl sin le smear band is observed for all the different concentration of eiF4H. 
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from 0.1 uM to 2uM. As illustrated in Figure 47B, only single smear band was 
observed for different concentrations of eiF4H although the RNA aptamer has more 
than one loop. The possible explanation is that the distance between the loops in the 
aptamer is not large enough to fit more than one eiF4H. 
The high binding affinity of RNA aptamer to eiF4H can help to interpret the 
question in (148). As shown in Figure 48, it is proposed in (148) that the slight but 
significant inhibition of HCV IRES directed LUC translation by the RNA aptamer is 
unlike by the dominant-negative eiF4A variant. This could be easily explained by 
assuming that eiF4H is one of the target proteins of the RNA aptamer that might be 
involved in the HCV IRES-directed LUC translation. 
A HCVIRES 
Cap b*Al,......,· ~-l#rl ... we., J 
c B 
no.20 00.21 J 
o 0.4 oe 12 t6 20 o 04 o.e1.2 t.6 2.0().IM) 
LUC - ...... ·--· 
CAT __. 
123456123 4 56 
I CAT/LUC(%) 100 82 37 17 6.6 3.21110060 lt 3.40.90.8 1 
Figure 48 - Inhibition of cap-dependent translation by RNA aptamers. (A) 
Schematic diagram of capped CAT /HCV /LUC mRNA (B-C) Translation products of 
capped CAT/HCV/LUC mRNA in RRL. Reaction mixtures were pre-incubated at 30°C for 
3 min with increasing amounts (0, 0.4, 0.8, 1.2, 1.6, and 2.0 11M in lanes 1-6, respectively) 
of no. 20 (B) and no. 21 (C) RNAs, followed by the addition of mRNA and 
35S methionine and further incubation for 60 min at 30°C. 148 
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4.3.3 RNA aptamer induces conformational change of the CTD of eiF4A. 
To investigate the conformational change of eiF4A upon binding to RNA 
aptamer, we performed single-molecule FRET experiments. The question we want 
to answer is whether RNA aptamer also interacts with the CTD when it binds to the 
full length eiF4A. The FRET efficiency histogram of freely diffusing eiF4A labeled at 
C-terminal domain (CTD) shows a peak at ~0.9 (4.0nm) (Figure 49A). The donor-
A B 
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~ 
c: 
Q) 
::I 
0" 
~ 
lL 
0.0 0.4 0.8 1.2 0.0 0.2 0.4 0.6 0.8 1.0 1.2 
FRET 
c D FRET 
400 
{;' 
c: 
Q) 
::I 
0" 200 ~ 
lL 
0.0 0.2 0.4 0.6 0.8 1.0 1.2 0.0 0.2 0.4 0.6 0.8 1.0 1.2 
FRET FRET 
Figure 49 - RNA aptamer induces conformational change of the CTD of eiF4A. (A) 
double-labeled e1F4A in solution. Both donor and acceptor are in CTD. (B) eiF4A/eiF4H 
complex binds to RNA hairpin. Only a subtle FRET change is observed. (C) The intra-
domain distance decreases when RNA aptamer binds to eiF4A. The FRET peak shifts to 
0.6. (D) eiF4H competes with eiF4A for biding to RNA aptamer, which is consistent with 
Figure 46, lane 3. Lines indicate the overall FRET fit of the population with multiple 
Gaussian peaks. Peak values were as follows; free eiF4A: 0.9; with RNA hairpin, eiF4A 
and AMPPNP: 0.8; with RNA aptamer: 0.6; with RNA aptamer and eiF4H: 0.6 and 0.9. 
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only species shows up as a zero-FRET population. In the presence of AMPPNP, 
eiF4H and RNA hairpin (Figure 49B), we observed a change of FRET from 0.9 to 0.8 
(4.4nm). When eiF4A adopts a closed conformation the CTD undergoes a subtle 
conformational change. 
Upon binding to RNA aptamer, a further shift of FRET peak from 0.9 to 0.6 
(5.2nm) was observed (Figure 49C). The result suggests that the eiF4A-CTD 
undergoes large conformational change when it binds to RNA aptamer. The gel shift 
assays in Figure 46 illustrate that although the RNA aptamer is screened based on 
the affinity of eiF4A, it can also strongly bind to eiF4H, because the loop structures 
of RNA aptamer are larger than 6nt. To gain further insight into the binding of RNA 
aptamer to eiF4A, we next examined whether eiF4H and eiF4A can compete for the 
binding to RNA aptamer. The result of the competition assay is illustrated in Figure 
49D. A mixture of "low FRET" and "high FRET" populations of eiF4A is observed: 
one is the population bound to RNA aptamer which shows FRET-0.6, the other one 
is the free eiF4A which shows FRET -0.9 because eiF4H competes with eiF4A for 
the binding to aptamer. The two well-defined FRET states can be fit with a double 
Gaussian distribution. 
4.4 Conclusion and Discussion 
In this chapter we have demonstrated that RNA aptamer and the small 
molecule hippuristanol can inhibit the binding to the RNA substrate or the helicase 
activity of the eiF4A/eiF4H complex respectively. The RNA aptamer can directly 
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compete with an RNA hairpin for binding to both eiF4A and eiF4H. Hippuristanol 
inhibits helicase activity by blocking the conformational change of eiF4A. This is 
consistent with the finding that hippuristanol inhibits eiF4Af RNA-dependent 
ATPase activity but does not inhibit ATP cross-linking to eiF4Af or eiF4Ac (21). 
The selected RNA aptamer .16.123 spans 45-70 A depending on its 
conformation, which might be sufficient to interact with the distended dumbbell 
domains ( <80 A) of eiF4A (110). When eiF4A binds to RNA aptamer, it adopts open 
conformation and the eiF4A-CTD also undergoes large conformation change in 
order to fit to RNA aptamer. We conclude that the inter-domain movement is 
necessary for helicase activity of eiF4A. 
For the first time we showed that RNA aptamer also has high affinity to 
eiF4H although it is screened by the affinity of eiF4A. This is consistent with our 
previous study in Chapter 2, which shows that eiF4H preferentially binds to the loop 
structure of RNA hairpin. 
The structure of the eiF4A-PDCD4 complex suggests that blocking the 
domain closure could be important strategy to inhibit the function of eiF4A (33, 
111) . Understanding the molecular mechanism how small molecules and RNA 
aptamers target DEAD-box family members would provide mechanistic insight into 
the properties of these proteins and help define their roles in normal and abnormal 
cellular and developmental processes. The recent clinical successes of therapeutic 
antibodies and small molecules in cancer treatment have established these agents as 
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the first cornerstone of molecular targeting therapy for cancers (10, 136, 137). More 
importantly a better understanding of targeted therapeutics in the context structure 
mechanism might lead to the design of new, effective and more specific targeted 
cancer therapies. 
4.5 Materials and methods 
4.5.1 In-vitro transcription of RNA aptamer 
The double-stranded DNA (dsDNA) template(S'- TAA TAC GAC TCA CTA TAG 
GGT AGA CGC TCA AGG GGA CCG CGC CCC ACA TGT GAG TGA GGC CGA AAC GT A 
GAT TCG ACA GGA GGC TCA CA -3') for the RNA aptamer was purchased from 
Integrated DNA Technologies (Coralville, lA). This dsDNA template was used to 
synthesize RNA using the T7 RNA polymerase in vitro transcription kit 
Megashortscript (Ambion, Austin, TX). The RNA aptamer was then loaded onto a 
12% denaturing polyacrylamide gel and run in 1x Tris-borate-EDTA (TBE). The 
desired single band was cut out of the polyacrylamide gel and eluted via a crush-
and-soak method, followed by ethanol precipitation. 
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Chapter 5: Conclusions and Discussion 
We endeavored to answer a few open questions on the structure-function 
relationship of intriguing RNA helicase of eiF4A, the godfather of DEAD-box protein. 
To this end this thesis work contains three studies that offer novel insights into 
molecular mechanism of eiF4A/eiF4H activity that may guide future basic research 
or applications development. 
The first study concerns the unwinding of RNA hairpin by eiF4A/eiF4H 
complex. We showed that eiF4H can significantly enhance the helicase activity of 
eiF4A by strongly binding both to loop structures within the RNA substrate as well 
as to eiF4A. Electrophoretic mobility shift assay (EMSA) shows that eiF4H binds to 
the amino-terminal domain (NTD) but not to the carboxy-terminal domain (CTD) of 
eiF4A. In the presence of ATP, the eiF4A/eiF4H complex exhibits rapid and 
repetitive cycles of unwinding andre-annealing. The unwinding kinetics of eiF4A in 
the presence of cofactor eiF4H are characterized with single exponential decay 
models. Although eiF4A-NTD itself shows similar bulk helicase activity as full length 
eiF4A, both NTD and CTD are necessary for the repetitive unwinding of RNA hairpin 
structure. ATP titration assays suggest that this process consumes a single ATP 
molecule per cycle. 
Second, we directly probed the conformational dynamics of double-labeled 
eiF4A during RNA unwinding using two methods: freely diffusion sm-FRET using 
confocal setup and surface immobilization sm-FRET with TIR setup and lipid 
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vesicles. We demonstrated that the eiF4A in the presence of eiF4H can repetitively 
unwind the RNA hairpin substrate by transitioning between an "open" and a 
"closed" conformation using the energy from ATP hydrolysis. Upon binding of an 
RNA hairpin and ATP, which is mediated by eiF4H, eiF4A adopts a closed 
conformation; after ATP hydrolysis, eiF4A returns to the open conformation, the 
RNA duplex is completely unwound, and the RNA is released, quickly re-annealing 
to reform the hairpin. 
Third, we further established that the RNA aptamer and the small molecule 
hippuristanol can inhibit the helicase activity of eiF4AjeiF4H with different 
mechanisms: the RNA aptamer can directly compete with an RNA hairpin for 
binding to both eiF4A and eiF4H, while hippuristanol does not interfere with the 
binding of eiF4AjeiF4H to the loop structure of RNA Instead, hippuristanol inhibits 
helicase activity by blocking the conformational change of eiF4A When e1F4A binds 
to RNA aptamer, it adopts open conformation and the eiF4A-CTD also undergoes 
large conformation change in order to fit to RNA aptamer. For the first time we 
showed that RNA aptamer also has high affinity to eiF4H although it is screened 
based on the affinity of eiF4A 
To explain our observations, we proposed that the eiF4A/eiF4H complex 
binds directly to mRNA loop structures and then destabilizes nearby duplexes. 
Duplex unwinding is mediated by the dynamic conformational transitions of the 
eiF4A, while maintaining contact with the eiF4H at its amino-terminal domain 
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(NTD). We concluded that the inter-domain movement is necessary for helicase 
activity of eiF4A. 
5.1 Mechanism how eiF4A/eiF4H interact with 5' UTR of mRNA. 
Figure 50 - Mechanism how eiF4A/eiF4H interact with 5' UTR of mRNA. eiF4A, 
through its binding to eiF4H, could be directed to the downstream the 5' UTR of an mRNA 
without having to scan from the 5' cap. The cartoon illustrates that multiple copies of 
eiF4HjeiF4A may bind to the mRNA at internal sites in the 5' UTR. With the energy from 
ATP hydrolysis, eiF4A can repetitively unwind the local duplex. 
eiF4A is the most abundant translation initiation factor, present at three 
copies per ribosome (149) and in a active growing mammalian cell there can be as 
many as 10 million ribosomes (150). It has been shown that during translation 
initiation copies of eiF4H could be cross-linked to an mRNA at sites up to 52 
nucleotides downstream from the cap and that this interaction was both cap and 
ATP dependent (151). It is proposed that, following the binding of eiF4E to the cap, 
multiple copies of eiF4H, and eiF4A may bind to the mRNA at internal sites in the 5' 
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UTR. Here we found that eiF4H stimulates the helicase activity of eiF4A to a 
significantly greater extent for RNA hairpin substrates with an internal single-
stranded loop than for RNA/DNA or RNA/RNA duplexes with a single-stranded 
overhang, and this suggested that binding affinity of eiF4A/eiF4H complexes to the 
loops of hairpins are much higher than to single-strand/double-strand junction. 
Therefore we postulated that one role of eiF4H is to facilitate the binding of eiF4A to 
specific secondary structures within mRNAs. The importance of these results is that 
we proposed a mechanism by which eiF4A, through its binding to eiF4H, could be 
directed during translation initiation to sites within the 5' UTR of an mRNA without 
having to scan from the 5' cap. 
Our data establish a basic mechanistic framework for the helicase activity 
and conformational dynamics of eiF4A/eiF4H complex. By combining the dynamic 
information obtained from these single-molecule experiments with structural and 
biochemical data, we provide quantitative and mechanistic understandings of how 
eiF4A/eiF4H complex functions. 
The eiF4A/eiF4H complex structure should serve as a framework to design 
therapeutics that mimic the RNA aptamer and small molecule hippuristanol. By 
combining the advantages of ensemble and single-molecule techniques, our 
experiments open avenues to probe the conformational change of DEAD-box 
proteins in real time and to correlate its kinetics with unwinding activity. Our 
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studies reveal new biological functions of eiF4A and link them with a structural 
understanding of molecular mechanism. 
5.2 Moving Forward 
While the single-molecule FRET experiments have displayed much promise 
to understand the molecular mechanism of eiF4A/eiF4H in vitro, significant efforts 
are needed to answer more open questions. In this section I'll highlight just some of 
the questions which need to be answered in the future. 
5.2.1 eiF4A jeiF4H and 5' UTR 
We are only just beginning to understand the molecular mechanism of how 
eiF4AjeiF4H complex unwinds the secondary structure of RNA. Here we used RNA 
hairpin as a simplified model system to study the interaction between eiF4A/eiF4H 
complex and RNA hairpin. A number of important questions concerning the function 
of eiF4A remain. In particular, little is known regarding how eiF4A interact with the 
two strands of the duplex during the unwinding. 
We proposed that during RNA unwinding the N-terminal domain (NTD) of 
eiF4A binds tightly to eiF4H, while C-terminal domain (CTD) may undergo free 
rotation. Another interesting question is whether eiF4A can induce conformational 
change to eiF4H when they bind to each other. 
To further prove the mechanism illustrated in Figure 50, we should use 
longer mRNA with rich secondary structure at 5' UTR as substrate to study how 
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eiF4A/eiF4H complex interacts with mRNA. With this longer biological substrate 
we can quantitatively characterize how many eiF4Hs or eiF4AjeiF4H complexes 
bind to the loop structures of 5' UTR. This could corroborate the model we proposed 
in Figure 50. 
5.2.2 eiF4B 
It is known that both 4B and 4H contain a well-defined RNA recognition 
motif (RRM) , and eiF4B, like eiF4H, enhances the helicase activity of (38, 109). It 
remains to be determined whether our results with eiF4H can be extrapolated to 
eiF4B or eiF4B may exhibit a complementary function. First we want to address 
how eiF4B interact with eiF4A and change its unwinding kinetics in real time. Next 
we should do comparative study of how eiF4H and eiF4B enhance the helicase 
activity of elF 4A with different substrates. This study will provide further 
insight into the molecular mechanisms of regulation of the eiF4A helicase activity by 
eiF4B. Specifically we need answer the following questions: Does eiF4B stimulate 
eiF4A activity by a repetitive unwinding manner? What is the unwinding kinetics of 
eiF4A/eiF4B complex? Does eiF4B need longer hairpin loop region or more 
complex secondary structure than eiF4H? 
5.2.3 Pateamnine and Silvestrol 
We have characterized the inhibition effect of small molecule hippuristanol 
on elF4A at the single-molecule level. It is known that pateamine inhibits the cap-
dependent eukaryotic translation initiation. In vitro studies showed that pateamine 
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decreases the association of eiF4A and eiF4G and promotes the association between 
eiF4A and e1F4B (22). Silvestro! is a potent anti-cancer compound in vivo that exerts 
its activity by affecting survival pathways as well as angiogenesis. Silvestro! reduces 
translation in normal mouse tissues without cytotoxicity (23), which make it a 
promising compound for the development of anticancer agents. It is shown that 
pateamine and silvestrol act as a chemical inducer of dimerization (CID) that forces 
the engagement between eiF4A and RNA (22, 23). Can we probe the conformation 
change of eiF4A when it binds to pateamine or silvestrol? Does pateamine or 
silvestrol change the kinetics of conformation change of eiF4A? 
5.2.4 Beyond eiF4A 
Crystal structures of helicases show different snapshots of possible domain 
orientations, ranging from an open conformation with two completely independent 
domains in a dumbbell-like arrangement to a tightly closed conformation (66, 96, 
152). The crystal structure of yeast eiF4A exhibits a completely open conformation, 
whereas closed conformations were observed for MjDEAD (153) and UAP56 (134, 
154). The closed form is considered the active enzyme, where the ATP-binding cleft 
is formed upon contact between the two domains. 
Most RNA helicases contain variations of a DEAD box motif along with six 
other highly conserved motifs. Research from many groups over the last two 
decades has demonstrated that the DEAD-box helicases extends well beyond ATP-
dependent duplex unwinding. For example, DEAD-box helicases have been shown to 
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promote duplex formation, displace proteins from RNA, and function as assembly 
platforms for larger ribonucleoprotein complexes. These diverse functions are all 
accomplished with the highly conserved helicase core, suggesting a common 
functional theme. 
The eukaryotic initiation factor eiF4A is a prototypical member of DEAD box 
RNA helicase that contains these seven core motifs together with only minimal 
flanking sequences. Here we characterized the activity of the core of DEAD-box 
helicase. What is the role of the flanking region of the other members? Could they 
work as a similar role as eiF4H which mediate the binding between the RNA 
substrate and the helicase core? Why should the cell utilize more than one helicase 
to facilitate translation initiation? 
Understanding how the translational stimulatory functions of eiF4A are 
coordinated and regulated is an important avenue for future research. As we gain 
better insight into the mechanisms of translation it is clear that the use of emerging 
technologies will lead to a more complete understanding of this paramount cellular 
process. In particular, single-molecule techniques are very powerful to bolster the 
models generated from molecular and biochemical studies. 
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Appendix 
A.l Experimental Protocol 
Part I PDMS channel Preparation 
1. Weight 7~10 g SYLGARD® 184 Silicone base and 0.7~1.0 g curing agent (using 
1ml Eppendorfpipette) [10:1 mixing ratio]. 
2. Mix well with Pasture pipette to see lots of bubbles. 
3. Degas the mixture for >2 hour at room temperature to remove all the bubbles. 
4. Clean brass mold and glass plate with Hexane, Acetone, Ethanol and diH20 and 
dry well with Nz [Hexane-7Acetone-7Ethanol-7diHz0-7Nz]. 
5. Pour the mixture on the brass mold [Remove the bubble with pipette tip if 
necessary]. 
6. Turn on the heater [setting: 70 °C -90 oc for overnight]. 
[Next day: Turn off the heater and let the mold cool down]. 
7. Open slightly on edges of the mold, wedge the razor and pull open. 
8. Cut PDMS edges and extra tails and put it on parafilm [lifetime: 2 weeks]. 
Part II Sandwich Assembly 
9. Clean sapphire window [Acetone-7 Ethanol -7diHz0-7 Nz] and put it on parafilm. 
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10. Clean PDMS channel [Isopropanol-7diHz0-7Nz] and center it on sapphire 
window. 
11. Put a piece of parafilm on the PDMS and tap to make sure binding between 
window and PDMS channel. 
12. Clean coverslip: place cover slips (glass or quartz) in a custom made TEFLON 
holder inside a 200ml beaker, and add 60ml HzS04 with 20ml of HzOz. Heat for 15 
min on a hot plate at 300°C. Cool down and wash with diHzO 3 times. Moves to a 
second holder placed in a beaker containing 10M NaOH. Incubate for 15 min. After 
incubation with NaOH, wash cover slips with diHzO, dry well with Nz and center it 
on PDMS channel. 
13. Put a piece of parafilm on the coverslip and tap gently to make sure seal in all 
area. [Otherwise it may have leakage between channels.] 
.....-----set screws---.... 
awe~Hp M ~ PDMS cha~nel - ·- · ~ m - · - · ·m needle 
sapphire wmdow 
= ] ( sandwich 
cell 
Figure 51- Assembly ofmicrofluidic cell 
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Part III Cell Assembly 
14. Clean the cell [Hexane-7Acetone-7Ethanol-7diHz0-7Nz]. 
15. Place the sandwich in the cell (Figure 51). 
16. Cut 6 25 Vz G needles ( -2mm) and insert needles through the holes. [Note the 
length of the needle to comply with cell. Make sure the needles are open. The 
needles should NOT touch the coverslip otherwise it may break the coverslip.] 
17. Tighten 6 set screws on the cell to fix the needles. 
18. Mix the Kwik-Cast™ PDMS and seal with the mixture on connections and around. 
19. Allow to dry for 15 minutes. 
20. Connect 30cm tubings (DIBA catalog#: DB600-11113) to the needles. 
21. Tighten 3 set screws to fix the cell on the adapter for the microscope. 
Part IV Surface coating and imaging 
22. Inject 150-200ul 0.1mgjml biotinylated bovine serum albumin (diluted in Tris 
buffer: 10mM Tris pH 7.5, SOmM NaCI) in each channel and incubate >1h or 
overnight at room temperature. Make sure there's neither leakage nor cross-talk 
between the channels. 
109 
23. Wash the channel with 1ml-2ml Tris buffer (10mM Tris pH 7.5, SOmM NaCl). 
Inject 150ul 0.1mgjml Streptavidine (diluted in Tris buffer) in each channel and 
incubate for 15-20 min. The channels can be sealed with plugs after Streptavidine 
coating. 
24. Prepare 3 samples with different concentrations of labeled DNA/RNA( diluted in 
Tris buffer): 0.1pM (usually not enough), 1pM and lOpM. Inject sample starting 
from 0.1pM. Check in the single-molecule image whether the concentration is 
sufficient, otherwise increase concentration. Usually you will have ~so immobilized 
molecules in a 40umx40um field of view (EMCCD camera). 
25. Slowly wash the free samples in a channel with imaging buffer (SOmM TRIS pH 
7.5, SOmM NaCl, saturated Trolox (>2 mM) (Sigma), SmM Protocatechuic acid 
(Sigma) and 0.1S11M Protocatechuate 3,4-Dioxygenase(Sigma)). At the same time 
acquire images from the EMCCD camera. 
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